07.08.2014 Views

LITIGATION UNLEASHED - Stikeman Elliott

LITIGATION UNLEASHED - Stikeman Elliott

LITIGATION UNLEASHED - Stikeman Elliott

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

A Guide to Ontario’s Proposed Secondary Market Liability Regime<br />

STIKEMAN ELLIOTT LLP<br />

CANADA’S GLOBAL LAW FIRM


<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

A Guide to Ontario’s Proposed Secondary Market Liability Regime<br />

Prepared by the securities and litigation departments of <strong>Stikeman</strong> <strong>Elliott</strong> LLP, Litigation Unleashed is<br />

your guide to Ontario’s proposed statutory secondary market civil liability regime. Better known as<br />

“Bill 198”, Ontario’s legislation amends the Securities Act to make it easier for security holders to sue<br />

corporations, their directors, officers, advisors and spokespersons. In addition, the legislation gives<br />

the Ontario Securities Commission new authority to pursue cases of market manipulation and other<br />

forms of securities fraud, while increasing the maximum sanctions that the Commission can levy.<br />

Litigation Unleashed takes you through the legislation in simple, clear language. The key points are<br />

summarized in easy-to-read charts and the text of the amendments is included.<br />

With offices on four continents, <strong>Stikeman</strong> <strong>Elliott</strong> LLP has a global presence unsurpassed in Canadian<br />

legal practice. With over 400 lawyers, we provide clients with seamless, integrated legal services in<br />

all areas of business law, most notably corporate finance, taxation, technology and M&A, including<br />

related litigation at all levels of Canadian courts. Domestically, we have offices in Montreal, Toronto,<br />

Vancouver, Calgary and Ottawa. Globally, we extend to New York, London, Hong Kong, and Sydney.<br />

We serve our clients wherever their business interests take them.<br />

For over 50 years we have been involved in many of Canada’s largest transactions and precedentsetting<br />

decisions. Our clients range from start-up firms to multinational corporations, domestic and<br />

foreign. The firm is a leader in both common law and Quebec civil law and offers its full spectrum of<br />

services in English and French. Our strength comes from the best and brightest law graduates<br />

through to leading specialists in every aspect of business law.<br />

The hallmarks of our practice are an in-depth understanding of business as well as of the law, an<br />

ability to find solutions that are both innovative and workable and, most importantly, a total<br />

commitment to our clients’ satisfaction.<br />

STIKEMAN ELLIOTT LLP BARRISTERS & SOLICITORS<br />

www.stikeman.com<br />

While every effort has been made to ensure the accuracy of this publication, it is a general overview only and does not constitute legal advice.<br />

For advice specific to your particular circumstances, please contact any office of <strong>Stikeman</strong> <strong>Elliott</strong> LLP.<br />

© <strong>Stikeman</strong> <strong>Elliott</strong> LLP July 2003


TABLE OF CONTENTS<br />

1 INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5<br />

1.1 WHAT IS BILL 198?. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5<br />

1.2 PURPOSE OF THIS GUIDE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5<br />

1.3 CURRENT STATUS OF THE AMENDMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6<br />

1.4 ORGANIZATION OF THIS GUIDE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6<br />

2 THE NEW STATUTORY CIVIL LIABILITY REGIME: Who, when and how much? . . . . . 7<br />

2.1 OVERVIEW OF THE AMENDMENTS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7<br />

2.1.1 Potential defendants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7<br />

2.1.2 Rights of action . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7<br />

2.1.3 Leave of the court . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8<br />

2.1.4 Defences. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8<br />

2.1.5 Damages . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8<br />

2.2 CAUSES OF ACTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9<br />

2.2.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9<br />

2.2.2 Documentary misrepresentation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9<br />

2.2.3 Public oral misrepresentations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11<br />

2.2.4 Failure to make timely disclosure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13<br />

2.2.5 Elements required to establish liability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14<br />

2.3 AVAILABLE DEFENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18<br />

2.3.1 Due diligence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18<br />

2.3.2 Safe harbour for forward-looking information . . . . . . . . . . . . . . . . . . . . . . . . . 19<br />

2.3.3 The plaintiff knew anyway . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20<br />

2.3.4 Material change confidentially disclosed to OSC . . . . . . . . . . . . . . . . . . . . . . . 20<br />

2.3.5 Reliance on experts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20<br />

2.3.6 Corrective action taken . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21<br />

2.3.7 Reliance on documents filed by other public companies . . . . . . . . . . . . . . . . . 21


2.4 DAMAGES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21<br />

2.4.1 The basic formulae . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22<br />

2.4.2 Proportionate liability. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23<br />

2.4.3 Limiting damages . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24<br />

2.5 OVERSIGHT OF STATUTORY CLAIMS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25<br />

3 THE OSC’S NEW POWERS: New offences, tougher sanctions . . . . . . . . . . . . . . . . . 27<br />

3.1 OVERVIEW OF ENFORCEMENT ALTERNATIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27<br />

3.1.1 Enforcement options available . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27<br />

3.1.2 Violations recognized prior to the amendments . . . . . . . . . . . . . . . . . . . . . . . . 27<br />

3.1.3 New violations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28<br />

3.1.4 Making a misleading or untrue statement. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28<br />

3.1.5 Market manipulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28<br />

3.1.6 Fraud. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29<br />

3.2 SECTION 127 ENFORCEMENT SANCTIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29<br />

3.2.1 Prior to the amendments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29<br />

3.2.2 New sanctions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30<br />

3.2.3 Penalties and disgorgement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30<br />

3.3 SECTION 122 QUASI-CRIMINAL ENFORCEMENT SANCTIONS . . . . . . . . . . . . . . . . . . . 30<br />

4 TIPS: Preventive medicine, new rules, and responding to litigation . . . . . . . . . . . . . . . . . . . . 31<br />

4.1 ISSUERS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31<br />

4.2 DIRECTORS AND OFFICERS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33<br />

4.3 AUDITORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34<br />

4.4 ESTABLISHING DEFENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35<br />

4.5 RESPONDING TO A FORMAL OR INFORMAL THREAT OF <strong>LITIGATION</strong> . . . . . . . . . . . . . 35<br />

5 CONCLUSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37<br />

APPENDICES<br />

APPENDIX A: FULL TEXT OF THE MAJOR AMENDMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . 39<br />

APPENDIX B: SUMMARY OF LIABILITIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53<br />

APPENDIX C: SUMMARY OF DEFENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63<br />

APPENDIX D: CALCULATING DAMAGES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71<br />

APPENDIX E: LIMITS ON DAMAGES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73<br />

APPENDIX F: PROPOSED CORPORATE GOVERNANCE RULES . . . . . . . . . . . . . . . . . . . . . . . 75


1 INTRODUCTION<br />

1.1 What is Bill 198?<br />

Ontario’s recent Securities Act amendments are better known as “Bill 198”, after the legislation<br />

that is now officially called the Keeping the Promise for a Strong Economy Act (Budget Measures),<br />

2002. A more descriptive (and less political) title for the amendments might have been the<br />

Another Avenue for Shareholders to Sue Corporations and their Directors and Officers Act. The new<br />

legislation represents the Ontario legislature’s attempt to restore investor confidence, which is<br />

widely believed – though without any empirical evidence – to have been damaged by Enron,<br />

Worldcom and other recent U.S. and Canadian scandals. Bill 198 also constitutes part of<br />

Ontario’s response to the major U.S. legislative initiative known as the Sarbanes-Oxley Act.<br />

1.2 Purpose of this guide<br />

The purpose of this guide is to:<br />

• summarize the recent changes to the Securities Act;<br />

• highlight the possible implication of those changes for public companies and their<br />

officers, directors, major shareholders, influential persons and experts;<br />

• provide some practical tips for minimizing potential exposure to a successful lawsuit; and<br />

• summarize the corporate governance-related rules released for comment on<br />

June 27, 2003, by the OSC.<br />

We have sought to simplify this complex legislation as much as possible in order to supply<br />

you with a user-friendly reference source that draws your attention to the significant issues.<br />

In adopting this approach, we have consciously elected to avoid the often prolix and<br />

heavily qualified language normally associated with legal writing, with the necessary caveat<br />

that this guide needs to be read in that context. Instead, we have included a set of charts as<br />

a roadmap through the amendments for each capital market participant affected. Our<br />

corporate governance and securities litigation teams would be pleased to meet with you to<br />

help you design a customized response to this new legislation.<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

5


1.3 Current status of the amendments<br />

Although Bill 198 has been passed by the Ontario legislature, some of its measures – including<br />

the civil liability regime discussed below – are not yet in force. Moreover, a number of the<br />

provisions of Bill 198 are to be amended by Bill 41, a piece of legislation that has not yet been<br />

passed. In the discussion below, we collectively refer to all of these changes – whether passed, in<br />

force, or merely introduced into the legislature – as “the amendments”, and we have written<br />

about them as though they will come into force without further amendment. In addition, a<br />

number of related regulations remain in the planning stage.<br />

1.4 Organization of this guide<br />

The discussion is organized as follows:<br />

• This introduction (Part 1)<br />

• New statutory civil liability regime: who and when—and how much? (Part 2)<br />

• The OSC’s new powers (Part 3)<br />

• Preventive measures: tips on how to prevent and respond to litigation (Part 4)<br />

• Text of the legislation (Appendix A)<br />

• Charts illustrating liabilities, defences, damages formulae, and limits on damages<br />

(Appendices B, C, D and E)<br />

• Summary of the OSC’s proposed new corporate governance rules (Appendix F)<br />

6 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


2<br />

THE<br />

NEW STATUTORY CIVIL LIABILITY REGIME:<br />

Who, when and how much?<br />

2.1 Overview of the amendments<br />

The following are brief descriptions of the most important aspects of the new liability regime,<br />

which are also summarized in the charts contained in the Appendices.<br />

2.1.1 Potential defendants<br />

The individuals and companies that may be exposed to liability by the<br />

amendments are described in the following chart (a fuller description is found<br />

in the Appendices):<br />

WHO?<br />

Responsible Issuer<br />

DESCRIPTION<br />

A “reporting issuer” or any other publicly-traded issuer with a “real and substantial<br />

connection to Ontario”, including a publicly-offered investment fund<br />

Director<br />

A director of either a “responsible issuer” or an “influential person”<br />

Officer<br />

An officer of either a “responsible issuer” or an “influential person”<br />

Investment Fund Manager<br />

Influential Person<br />

Expert<br />

Spokesperson<br />

A “person who has the power and exercises the responsibility to direct the affairs of an<br />

investment fund”. For the purpose of liability under the amendments, investment fund<br />

managers are generally classed as “influential persons”<br />

A “control person”, a “promoter”, an insider (who is not a director or senior officer of<br />

a responsible issuer) or an investment fund manager (if the responsible issuer is an<br />

investment fund)<br />

A “person or company whose profession gives authority to a statement made in a<br />

professional capacity by the person or company including, without limitation, an<br />

accountant, actuary, appraiser, auditor, engineer, financial analyst, geologist or lawyer”<br />

A person with “actual, implied or apparent authority to speak on behalf of a<br />

responsible issuer” or “on behalf of an influential person”<br />

2.1.2 Rights of action<br />

The Securities Act currently provides a statutory cause of action only to investors who<br />

purchase securities sold to them pursuant to a prospectus, offering memorandum or<br />

securities exchange take-over bid circular (commonly known as the “primary market”).<br />

The amendments will provide an additional statutory cause of action for investors who<br />

purchase or sell securities from third parties in the market (commonly known as the<br />

“secondary market”) by granting a right of action for:<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

7


• a misrepresentation made by or on behalf of a responsible issuer in its disclosure<br />

documents or in public oral statements; and<br />

• a responsible issuer’s failure to make timely disclosure of a material change.<br />

In contrast to the common law cause of action for negligent misrepresentation,<br />

which requires each plaintiff to prove that it relied to its detriment on the alleged<br />

misrepresentation, the amendments will create a statutory right of action “without regard<br />

to whether” the purchaser or seller of securities relied on the alleged misrepresentation.<br />

That is, reliance is not required and not relevant.<br />

2.1.3 Leave of the court<br />

Although the amendments speak of a statutory “right” of action, the prospective<br />

plaintiff can commence a proceeding under these provisions only with the leave of the<br />

court. Leave will be granted only if the court is satisfied that:<br />

• the action is being brought in good faith; and<br />

• there is a “reasonable possibility” that the action will be resolved<br />

in favour of the plaintiff.<br />

2.1.4 Defences<br />

While the amendments create statutory causes of action, they also create a number of<br />

defences that may preclude liability or limit damages in certain situations. These<br />

defences, discussed in more detail in Section 2.3 below, include:<br />

• due diligence;<br />

• properly qualified forward-looking information;<br />

• plaintiff knew of material change or misrepresentation;<br />

• material change was confidentially disclosed to the OSC;<br />

• reasonable reliance on an expert;<br />

• corrective action taken; and<br />

• reasonable reliance on representations contained in a third party’s public filing.<br />

2.1.5 Damages<br />

The amendments include a set of formulae for the calculation of damages arising<br />

from a misrepresentation or failure to make timely disclosure of a material change.<br />

It is noteworthy that the amendments limit damages available under the new rights<br />

of action by providing for proportionate (i.e. not joint and several) liability and an<br />

overall cap on damages for specific categories of defendants in certain circumstances.<br />

8 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


2.2 Causes of action<br />

2.2.1 Introduction<br />

Investors will now have a statutory right of action where they acquired or disposed of<br />

securities while there was an uncorrected misrepresentation in a document or a public<br />

oral statement or while there was a failure to make timely disclosure of a material<br />

change as required by the Securities Act.<br />

This statutory right of action does not prevent an investor from suing for fraudulent<br />

or negligent misrepresentation or on any other basis that might be allowed for under<br />

the common law or under any other statutory scheme (e.g. a claim for oppression).<br />

Such alternative approaches could be taken separately or possibly in tandem with a<br />

proceeding under the Act. Similarly, the limitations on damages specified in the<br />

amendments are not applicable to common law causes of action.<br />

The statutory rights of action created by the amendments are summarized in chart<br />

form as Appendix B.<br />

In considering issues of liability under the provisions discussed below, it should be<br />

remembered that the amendments define “responsible issuer” to include publicly offered<br />

investment funds and “influential person” to include an investment fund manager.<br />

Also, note that purchasers or sellers of derivative securities, such as options, and<br />

guaranteed securities, also can seek damages.<br />

2.2.2 Documentary misrepresentation<br />

MEANING OF “DOCUMENT”<br />

“Document” is defined in the amendments to mean any written communication<br />

(including electronic communications):<br />

• required to be filed with the OSC (or which is not required but nevertheless filed<br />

with the OSC), a government securities or corporate agency or a stock exchange or<br />

similar marketplace; or<br />

• the content of which could reasonably be expected to affect the market price or value<br />

of the security of the issuer.<br />

This is an extremely broad provision that could apply to press releases, content on<br />

websites and marketing materials, among other things.<br />

WHEN A DOCUMENTARY MISREPRESENTATION OCCURS<br />

A documentary misrepresentation occurs when any of the following releases a<br />

document containing a misrepresentation:<br />

• a responsible issuer;<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

9


• an influential person; or<br />

• a person or company with actual, implied or apparent authority to act on<br />

behalf of a responsible issuer or on behalf of an influential person.<br />

WHO CAN SUE<br />

A documentary misrepresentation creates a statutory right of action for damages in<br />

favour of anyone who acquires or disposes of an issuer’s securities during the period<br />

between the document’s release and the public correction of the misrepresentation,<br />

even if the misrepresentation did not influence the person’s decision to acquire or<br />

dispose of the security.<br />

WHO CAN BE SUED<br />

Who can be sued depends on whether the document containing the misrepresentation<br />

was released by the responsible issuer or by an influential person (including, in each<br />

case, a person or company with actual, implied or apparent authority to act on its behalf).<br />

Where document released by responsible issuer<br />

In the case of a misrepresentation contained in a document released by or on behalf of a<br />

responsible issuer, the list of parties against whom a statutory right of action may exist<br />

is as follows:<br />

• the responsible issuer;<br />

• its directors at the time of release (whether or not they authorized, permitted or<br />

acquiesced in the release);<br />

• any of its officers who authorized, permitted or acquiesced in the release;<br />

• each influential person, and each director and officer of an influential person, who<br />

– knowingly influenced the responsible issuer, or any person or company acting<br />

on its behalf, to release the document; or<br />

– knowingly influenced a director or officer of the responsible issuer to<br />

authorize, permit or acquiesce in the release of the document; and<br />

• each expert, where<br />

– the misrepresentation is also contained in a report, statement or opinion<br />

made by the expert,<br />

– the document includes, summarizes or quotes from the report,<br />

statement or opinion of the expert, and<br />

– if the document was released by a person other than the expert,<br />

the expert consented in writing to the use of the report, statement or<br />

opinion in the document.<br />

10 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


Where document released by influential person<br />

In the case of a misrepresentation contained in a document that relates to a<br />

responsible issuer released by or on behalf of an influential person, there may exist a<br />

statutory right of action for damages against:<br />

• the responsible issuer, if any of its directors or officers (or, if an investment fund,<br />

its manager) authorized, permitted or acquiesced in the release of the document;<br />

• any director or officer of the responsible issuer who authorized, permitted or<br />

acquiesced in the release of the document;<br />

• the influential person;<br />

• any director or officer of the influential person who authorized, permitted or<br />

acquiesced in the release of the document; and<br />

• each expert, where<br />

– the misrepresentation is also contained in a report, statement or opinion<br />

made by the expert,<br />

– the document includes, summarizes or quotes from the report, statement or<br />

opinion of the expert, and<br />

– if the document was released by a person other than the expert,<br />

the expert consented in writing to the use of the report, statement or<br />

opinion in the document.<br />

2.2.3 Public oral misrepresentation<br />

MEANING OF “PUBLIC ORAL STATEMENT”<br />

A public oral statement is defined for the purposes of the new amendments to mean<br />

“an oral statement made in circumstances in which a reasonable person would believe<br />

that information contained in the statement will become generally disclosed”.<br />

Interestingly, the use of the term “generally disclosed” in this manner may affect<br />

traditional interpretations of these words. It may be that they can no longer be<br />

equated with the issuance of a press release.<br />

WHEN PUBLIC ORAL MISREPRESENTATION OCCURS<br />

A public oral misrepresentation occurs when a public oral statement:<br />

• relates to the business or affairs of a responsible issuer;<br />

• is made by one of the following:<br />

– a person with actual, implied or apparent authority to speak on behalf of the<br />

responsible issuer,<br />

– an influential person, or<br />

– a person with actual, implied or apparent authority to speak on behalf of the<br />

influential person; and<br />

• contains a misrepresentation.<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

11


WHO CAN SUE<br />

As in the case of documentary misrepresentation, any person or company who acquired<br />

or disposed of the responsible issuer’s securities during the period between the time of<br />

the public oral statement and the time when the misrepresentation was publicly<br />

corrected has a statutory right of action for damages.<br />

WHO CAN BE SUED<br />

Who can be sued depends on whether the public oral statement was made by a<br />

person with authority to speak on behalf of the responsible issuer or by an<br />

influential person (including, in the latter case, a person with actual, implied or<br />

apparent authority to speak on its behalf).<br />

Where statement made on behalf of responsible issuer<br />

In the case of a public oral statement containing a misrepresentation about a<br />

responsible issuer made by a person with actual, implied or apparent authority to<br />

speak on behalf of the responsible issuer, the list of parties against whom a statutory<br />

right of action for damages may exist is as follows:<br />

• the responsible issuer;<br />

• any director or officer of the responsible issuer who authorized, permitted or<br />

acquiesced in the making of the public oral statement;<br />

• the person who made the public oral statement;<br />

• each influential person, and each director and officer of an influential person,<br />

who knowingly influenced either the person who made the public oral statement to<br />

make the public oral statement or a director or officer of the responsible issuer to<br />

authorize, permit or acquiesce in the making of the public oral statement; and<br />

• each expert, where<br />

– the misrepresentation is also contained in a report, statement or opinion<br />

made by the expert,<br />

– the public oral statement includes, summarizes or quotes from the report,<br />

statement or opinion of the expert, and<br />

– if the public oral statement was made by a person other than the expert,<br />

the expert consented in writing to the use of the report, statement or<br />

opinion in the document.<br />

Where statement made by influential person<br />

In the case of a public oral statement containing a misrepresentation about a<br />

responsible issuer made by an influential person, or on its behalf by a person with<br />

actual, implied or apparent authority to do so, there may exist a statutory right of<br />

action for damages against:<br />

• the responsible issuer, if any of its directors or officers (or, if an investment<br />

fund, its manager) authorized, permitted or acquiesced in the making of<br />

the public oral statement;<br />

12 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


• any director or officer of the responsible issuer who authorized, permitted or<br />

acquiesced in the making of the public oral statement;<br />

• the person who made the public oral statement;<br />

• the influential person;<br />

• any director or officer of the influential person who authorized, permitted or<br />

acquiesced in the making of the public oral statement; and<br />

• each expert, where<br />

– the misrepresentation is also contained in a report, statement or opinion<br />

made by the expert,<br />

– the public oral statement includes, summarizes or quotes from the report,<br />

statement or opinion of the expert, and<br />

– if the public oral statement was made by a person other than the expert, the<br />

expert consented in writing to the use of the report, statement or opinion in<br />

the public oral statement.<br />

Where a person making a public oral statement containing a misrepresentation about<br />

the responsible issuer has done so with apparent but not implied or actual authority<br />

of either an influential person or the responsible issuer to do so, only that person is<br />

potentially liable in respect of trades between the time of his or her public oral<br />

statement and the public correction of that statement. Nevertheless, any other person<br />

who could have been liable had the “rogue” spokesperson been fully authorized to<br />

make the misleading statement will still be potentially liable for any trades that took<br />

place after that other person became, or should reasonably have become, aware of the<br />

rogue spokesperson’s misrepresentation (and before the public correction).<br />

2.2.4 Failure to make timely disclosure<br />

WHEN FAILURE TO MAKE TIMELY DISCLOSURE OCCURS<br />

Failure to make timely disclosure occurs when the responsible issuer fails “to disclose a<br />

material change in the manner and at the time required” under the Securities Act.<br />

Under the Act, reporting issuers are generally required to disclose material changes<br />

forthwith by press release and a material change report. Confidential filings are<br />

permitted in certain circumstances for a limited period of time.<br />

WHO CAN SUE<br />

A person or company who acquires or disposes of the issuer’s securities between<br />

the time when the material change was required to be disclosed and its subsequent<br />

disclosure has a statutory right of action for damages.<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

13


WHO CAN BE SUED<br />

A right of action for failure to make timely disclosure exists against:<br />

• the responsible issuer;<br />

• any director or officer of the responsible issuer who authorized, permitted or<br />

acquiesced in the failure;<br />

• any influential person and any director or officer of an influential person who<br />

knowingly influenced the responsible issuer, or any person or company acting on its<br />

behalf, in the failure to make timely disclosure; and<br />

• any influential person and any director or officer of an influential person who<br />

knowingly influenced a director or officer of the responsible issuer to authorize,<br />

permit or acquiesce in the failure to make timely disclosure.<br />

2.2.5 Elements required to establish liability<br />

The plaintiff is required to establish a number of elements in order to establish liability.<br />

These elements will vary depending on the class of possible defendant and the nature of<br />

the claim. The following is a summary of the elements that a plaintiff needs to prove<br />

in order to establish liability for each type of defendant. In each case, potential liability<br />

is subject to the available defences discussed in Section 2.3 (which are also summarized<br />

in Appendix C).<br />

RESPONSIBLE ISSUERS<br />

Core documents and failures to make timely disclosure<br />

The responsible issuer will be potentially liable upon mere proof of the<br />

misrepresentation for any loss caused to an investor who traded securities of the<br />

reporting issuer during the period in which the misrepresentation contained in a<br />

“core document” remained publicly uncorrected. Similarly, it will be potentially<br />

liable upon mere proof of a failure to make timely disclosure of a material change.<br />

Essentially, core documents are those documents that are filed with the securities<br />

regulator in accordance with the issuer’s statutory obligation. These are: a prospectus,<br />

a take-over bid circular, an issuer bid circular, a directors’ circular, a rights offering<br />

circular, management’s discussion and analysis, an annual information form, an<br />

information or proxy circular, annual financial statements, interim financial statements<br />

and (in most cases, with the notable exception of directors) material change reports.<br />

Non-core documents and public oral statements<br />

The requirements for the plaintiff to establish liability of a responsible issuer related to<br />

disclosure in non-core documents and public oral statements are more onerous. The<br />

plaintiff must also demonstrate:<br />

• advance knowledge that the statement or document contained a misrepresentation;<br />

• deliberate avoidance of such knowledge; or<br />

• gross misconduct<br />

14 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


on the part of the issuer. Gross misconduct can be either an action or a failure to act “in<br />

connection with the failure to make timely disclosure”. The amendments specify a list of<br />

criteria for deciding whether conduct is “gross misconduct”. See Section 2.3.1 below.<br />

DIRECTORS<br />

Core documents<br />

Directors will be potentially liable upon mere proof of the misrepresentation for any<br />

loss caused to an investor who traded securities of the responsible issuer during the<br />

period in which a misrepresentation contained in a core document remained<br />

publicly uncorrected.<br />

Material change reports are not considered core documents for directors.<br />

Non-core documents, public oral statements and failure to make timely disclosure<br />

The requirements for the plaintiff to establish liability of a director related to disclosure<br />

in non-core documents and public oral statements are more onerous. The plaintiff must<br />

also demonstrate:<br />

• advance knowledge of the misrepresentation;<br />

• deliberate avoidance of such knowledge; or<br />

• gross misconduct<br />

on the part of the director.<br />

With respect to a failure to make timely disclosure of a material change, knowledge of<br />

the director must have been as of the time the failure to disclose first occurred, and<br />

must be knowledge of the change and that it was a material change. Deliberate<br />

avoidance of knowledge relates to the period of time leading up to the time the failure<br />

first occurred.<br />

OFFICERS<br />

Core documents and failure to make timely disclosure<br />

Plaintiffs asserting a claim against officers of the responsible issuer with respect to core<br />

documents must establish, in addition to proving the existence of the<br />

misrepresentation, that the officers authorized, permitted or acquiesced in the release of<br />

the core document in order to establish liability for the losses suffered during the<br />

relevant period. Similarly, a plaintiff must prove that an officer authorized, permitted<br />

or acquiesced in the failure to make timely disclosure of a material change.<br />

Non-core documents and public oral statements<br />

The requirements for the plaintiff to establish liability of an officer related to disclosure<br />

in non-core documents and public oral statements are more onerous. The plaintiff must<br />

also establish:<br />

• advance knowledge of the misrepresentation;<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

15


• deliberate avoidance of such knowledge; or<br />

• gross misconduct<br />

on the part of the officer.<br />

INFLUENTIAL PERSONS<br />

Who they are<br />

An influential person can be a “control person”, a “promoter” or an insider other than an<br />

insider who is a director or “senior officer” of an issuer. “Control person” is defined in the<br />

amendments as a person or company who holds a sufficient number of voting rights<br />

attached to all outstanding voting securities of an issuer to affect materially the control of the<br />

issuer. There is a presumption that this is the case where the person’s or company’s holding<br />

exceeds 20% of the voting rights attached to all outstanding voting securities of an issuer.<br />

Note that the provision, including the presumption for holdings in excess of 20%, also<br />

applies to any persons or companies acting in concert (“by virtue of an agreement,<br />

arrangement, commitment or understanding”), where such persons or companies hold in<br />

total a sufficient number of voting rights to materially affect control of the issuer.<br />

Core documents<br />

Influential persons and their officers and directors who “knowingly influence”:<br />

• the responsible issuer;<br />

• any person acting on behalf of the responsible issuer; or<br />

• a director or officer of the responsible issuer<br />

to release the core document (in the first two cases) or to authorize, permit or acquiesce<br />

in the release of the core document (in the third case), are potentially liable for<br />

misrepresentations contained in the core document.<br />

Non-core documents, public oral statements and failure to make timely disclosure<br />

The requirements for the plaintiff to establish liability of an influential person or its<br />

directors and officers for a misrepresentation made in a non-core document or public<br />

oral statement released by the issuer, or the issuer’s failure to make timely disclosure of<br />

a material change, are more onerous. The plaintiff must establish:<br />

• advance knowledge of a misrepresentation or failure to disclose<br />

a material fact;<br />

• deliberate avoidance of such knowledge; or<br />

• gross misconduct<br />

on the part of an influential person.<br />

16 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


Documents and public oral statements of an influential person<br />

In addition, influential persons may also be held liable if the plaintiff establishes that they<br />

(or a person or company on their behalf) released a document or made a public oral<br />

statement that “relates to a responsible issuer and that contains a misrepresentation”. Any<br />

director or officer of an influential person who “authorized, permitted or acquiesced” in the<br />

release of such a document or the making of the public oral statement may be liable as well.<br />

However, in all these cases, the plaintiff must also establish that the influential person,<br />

director or officer:<br />

• had advance knowledge of the misrepresentation;<br />

• deliberately avoided obtaining such knowledge; or<br />

• engaged in gross misconduct.<br />

EXPERTS<br />

Experts are potentially liable where:<br />

• a core or non-core document containing a misrepresentation, or<br />

• a public oral statement containing a misrepresentation<br />

is released or made by the issuer (or a person with actual, implied or apparent<br />

authority to release the document or to speak on behalf of the issuer), if each of the<br />

following is also true:<br />

• the misrepresentation is also contained in a report, statement or opinion<br />

made by the expert;<br />

• the document or public oral statement includes, summarizes or quotes from the<br />

report, statement or opinion of the expert; and<br />

• the expert either released the document or made the statement itself or consented in<br />

writing to the use of the report, statement or opinion in the document or public<br />

oral statement.<br />

Experts cannot be held liable under these provisions for a failure to make timely disclosure.<br />

SPOKESPERSONS<br />

Spokespersons represent an additional category of potential defendants who do not fit<br />

into any of the other enumerated categories. They are potentially liable where they<br />

make a public oral statement relating to the responsible issuer while having actual,<br />

implied or apparent authority to speak on behalf of that issuer or an influential person.<br />

The plaintiff would have to prove, however, that the spokesperson:<br />

• knew, at the time that the public oral statement was made, that it contained<br />

the misrepresentation;<br />

• deliberately avoided acquiring such knowledge; or<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

17


• was, through action or failure to act, guilty of gross negligence in connection<br />

with the release of the document or the making of the public oral statement that<br />

contained the misrepresentation.<br />

2.3 Available defences<br />

The amendments create a number of statutory defences which may, if established, protect a<br />

defendant from a finding of liability. These defences are set out in chart form in Appendix C.<br />

2.3.1 Due diligence<br />

Any defendant can avoid liability for a misrepresentation (or failure to make timely<br />

disclosure) by proving that, before the document was released, or the public oral<br />

statement was made (or the failure to make timely disclosure first occurred) it had<br />

“conducted or caused to be conducted a reasonable investigation” and that at the time<br />

of the release of the document or of the making of the statement (or of the failure to<br />

make timely disclosure), it “had no reasonable grounds to believe” that the document<br />

or public oral statement contained the misrepresentation (or that the failure to make<br />

timely disclosure would occur).<br />

The court’s determination of whether an investigation was “reasonable” is to be based<br />

on a number of factors set out in the amendments. These factors are the same criteria<br />

to be used by the court in deciding whether a defendant’s behaviour constituted<br />

“gross misconduct”, namely:<br />

• the nature of the responsible issuer;<br />

• the knowledge, experience and function of the person or company;<br />

• the office held, if the person was an officer;<br />

• the presence or absence of another relationship with the responsible issuer, if the<br />

person was a director;<br />

• the existence, if any, and the nature of any system designed to ensure that the<br />

responsible issuer meets its continuous disclosure obligations;<br />

• the reasonableness of reliance by the person or company on the responsible issuer’s<br />

disclosure compliance system and on the responsible issuer’s officers, employees and<br />

others whose duties would in the ordinary course have given them knowledge of the<br />

relevant facts;<br />

• the period within which disclosure was required to be made under the applicable law;<br />

• in respect of a report, statement or opinion of an expert, any professional standards<br />

applicable to the expert;<br />

• the extent to which the person or company knew, or should reasonably have known,<br />

the content and medium of dissemination of the document or public oral statement;<br />

• in the case of a misrepresentation, the role and responsibility of the person or<br />

company in the preparation and release of the document or the making of the public<br />

oral statement containing the misrepresentation or the ascertaining of the facts<br />

contained in that document or public oral statement; and<br />

18 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


• in the case of a failure to make timely disclosure, the role and responsibility of the<br />

person or company involved in a decision not to disclose the material change.<br />

Disclosure compliance procedures designed to ensure that a matter that ought to be<br />

disclosed comes to the attention of management (and, where appropriate, the board of<br />

directors) in a timely manner may assist greatly in satisfying the requirements of this<br />

defence and are therefore highly recommended.<br />

2.3.2 Safe harbour for forward-looking information<br />

DOCUMENTS<br />

A person or company is not liable for a misrepresentation in forward-looking<br />

information in a document if:<br />

• the document contains “reasonable cautionary language” identifying the<br />

forward-looking information as such and identifying material factors that could<br />

cause actual results to differ materially from a conclusion, forecast or projection<br />

in the forward-looking information;<br />

• the document states the material factors or assumptions that were applied in<br />

drawing a conclusion or in making a forecast or projection set out in the<br />

forward-looking information;<br />

• the cautionary language and statement of material factors and assumptions applied<br />

appear proximate to the forward-looking information; and<br />

• the person or company had a reasonable basis for drawing the conclusions or making<br />

the forecast or projection.<br />

The amendments define “forward-looking information” as all “disclosure regarding<br />

possible events, conditions or results of operations, that is based on assumptions about<br />

future economic conditions and courses of action and includes future-oriented<br />

financial information with respect to prospective results of operations, financial<br />

position or cash flows that is presented whether as a forecast or projection”.<br />

The limitation on liability for forward-looking information extends to forwardlooking<br />

information contained in a prospectus, offering memorandum or circular<br />

(as defined in the Securities Act), with the exception of (i) financial statements,<br />

and (ii) forward-looking information in documents released in connection with<br />

an initial public offering.<br />

PUBLIC ORAL STATEMENTS<br />

In the case of a claim concerning public oral statements containing forward-looking<br />

information, the “cautionary language” requirement is satisfied where the person<br />

making the statement provides the following cautionary information:<br />

• that the oral statement contains forward-looking information;<br />

• that the actual results could differ materially from a conclusion, forecast or<br />

projection in the forward-looking information; and<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

19


• that certain material factors or assumptions were applied in drawing a conclusion<br />

or making a forecast or projection included in the forward-looking information.<br />

Having done this, the person must then direct his or her listeners to additional<br />

information contained in a “readily-available document” or part of a document.<br />

For the purposes of the Act, a document filed with the OSC counts as a<br />

“readily-available document”.<br />

2.3.3 The plaintiff knew anyway<br />

No liability will attach to a defendant with respect to a misrepresentation or a failure to<br />

make timely disclosure if the defendant can prove that the plaintiff acquired or<br />

disposed of the issuer’s security (i) “with knowledge” that the document or public oral<br />

statement contained a misrepresentation or (ii) “with knowledge” of the material<br />

change, as applicable.<br />

2.3.4 Material change confidentially disclosed to OSC<br />

There is no liability for failing to make timely disclosure if:<br />

• the defendant proves that the material change was disclosed in a material change<br />

report filed with the OSC on a confidential basis;<br />

• the issuer had a reasonable basis for making the disclosure on a confidential basis;<br />

• public disclosure of the material change was made promptly when the basis for<br />

confidentiality ceased to exist;<br />

• no document was released and public oral statement was made during the<br />

confidential filing period that contained a misrepresentation due to the undisclosed<br />

material change; and<br />

• where the material change became publicly known in a manner other than the<br />

manner required under the Securities Act, the issuer publicly disclosed the material<br />

change promptly.<br />

2.3.5 Reliance on experts<br />

No liability will attach to a defendant with respect to any part of a document or public<br />

oral statement that includes, summarizes or quotes from a report, statement or opinion<br />

made by the expert if the expert has provided its written consent to the use of the<br />

report, statement or opinion. The defence is not available to the expert on whom<br />

reliance was placed.<br />

A defendant cannot use this defence if it knew or had reasonable grounds to believe<br />

that there was a misrepresentation or if the disclosure did not “fairly represent” the<br />

expert’s report, statement or opinion.<br />

20 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


2.3.6 Corrective action taken<br />

Potential defendants, other than responsible issuers, are not liable with respect to<br />

misrepresentations and failures to make timely disclosure made without their knowledge<br />

or consent if they take prompt corrective action by promptly advising the board of<br />

directors of the responsible issuer of the misrepresentation or failure and, if no correction<br />

or disclosure is made within two business days, promptly advising the OSC in writing of<br />

the misrepresentation or failure. Defendants who are prohibited by law or professional<br />

confidentiality rules from disclosing this information to the OSC are not required to<br />

make disclosure to the OSC in order to satisfy the defence.<br />

2.3.7 Reliance on documents filed by other public companies<br />

There is no liability for an oral or documentary misrepresentation where the defendant<br />

proves that:<br />

• the misrepresentation was also contained in a document filed by or on behalf of<br />

another person or company, other than the responsible issuer, with the OSC or any<br />

other securities regulator in Canada, or with any stock exchange, without having<br />

been subsequently corrected, prior to the defendant’s repetition of the<br />

misrepresentation, by filing a correction with the relevant regulator or exchange;<br />

• the defendant’s document or public oral statement contained a reference identifying<br />

the document that was the source of the misrepresentation; and<br />

• when the document was released or the public oral statement was made, the person<br />

or company did not know and had no reasonable grounds to believe that the<br />

document or public oral statement contained a misrepresentation.<br />

The amendments refer to this as derivative information.<br />

2.4 Damages<br />

Under the amendments, persons who acquire or dispose of an issuer’s securities while there is an<br />

uncorrected misrepresentation, or a failure to disclose a material change on a timely basis, may<br />

recover damages. The damages available are limited in three ways:<br />

• The damages must be calculated in accordance with the formulae set out in the amendments.<br />

• The court is required to fix the proportionate share of those damages payable by each defendant<br />

found liable, recovery against each defendant being limited, subject to certain exceptions, to its<br />

respective share of the total damages assessed for all plaintiffs after applying the formulae.<br />

• The amount payable by each particular defendant found liable may be further limited,<br />

again subject to certain exceptions, to various liability limits specific to each<br />

category of defendant.<br />

These three limitations are discussed in the following subsections.<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

21


2.4.1 The basic formulae<br />

The amendments set out two basic formulae for the computation of damages. One<br />

formula applies to plaintiffs who acquired securities during the period of an uncorrected<br />

misrepresentation or failure to disclose a material change and paid too much as a result.<br />

The other formula applies to plaintiffs who sold their securities during such a period for<br />

too little. (For example, in the first case, the acquisition price may have been too high<br />

as a result of an overly optimistic misrepresentation, while in the second, the disposition<br />

price may have been too low as a result of an excessively pessimistic one.)<br />

WHERE AN ACQUIRING PLAINTIFF PAID TOO MUCH<br />

Where security holders paid too much for their securities during the period of an<br />

uncorrected misrepresentation or failure to disclose a material change, the relevant<br />

concepts are as follows:<br />

• The purchase period: the period between the occurrence of the misrepresentation or<br />

failure to disclose a material change and its correction;<br />

• The ten trading day period: the period immediately after the correction of the<br />

misrepresentation or failure to disclose a material change;<br />

• Purchase price: symbolized in the formulae below as P;<br />

• Actual disposition price: the price at which the plaintiff actually sold its securities<br />

subsequent to the correction of the misrepresentation or failure to disclose a material<br />

change (ADP); and<br />

• Benchmark price: the trading price during the ten trading day period (BP).<br />

Subject to the damages limits discussed in Section 2.4.3 below, damages (D) are<br />

determined by reference either to plaintiff’s actual loss (P – ADP) or to a more<br />

objective loss figure, calculated as (P – BP). The damages formulae provided for under<br />

the amendments where an investor purchases securities during the purchase period are<br />

as follows:<br />

• For securities disposed of during the ten trading day period after the correction is<br />

made public, D = P – ADP (i.e. plaintiff’s actual loss)<br />

• For securities disposed of thereafter, D = P – the greater of BP and ADP (i.e. the<br />

lesser of the objective loss and the plaintiff’s actual loss)<br />

• For securities not disposed of at all, D = P – BP (i.e. the objective loss)<br />

WHERE A SELLING PLAINTIFF RECEIVED TOO LITTLE<br />

There is also a parallel set of calculations for cases in which security holders sold their<br />

securities for too low a price during the period of an uncorrected misrepresentation or<br />

failure to disclose a material change. The applicable concepts in such a case are virtually<br />

identical to those that apply in the first type of case. To put it briefly, selling security<br />

holders who repurchase the securities within the ten trading day period can recover<br />

their actual loss, i.e. the shortfall between the price at which the securities were sold and<br />

22 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


the price paid to repurchase them. Those who repurchase the securities after the ten<br />

trading day period can recover the lesser of their actual loss and the objective loss (the<br />

latter being defined as the shortfall between the price at which the securities were sold<br />

and the benchmark price set out above). Those investors who do not repurchase the<br />

securities following a correction can recover the objective loss. In all cases, these<br />

potential recoveries are subject to the damages limits discussed in Section 2.4.3 below.<br />

WHERE LOST VALUE WAS CAUSED BY AN EXTRANEOUS FACTOR<br />

In either case, the defendant is not responsible for paying damages with respect to lost<br />

value that it can prove was unrelated to the misrepresentation or failure to make timely<br />

disclosure of a material change.<br />

These formulae are set out in chart form in Appendix D.<br />

2.4.2 Proportionate liability<br />

After assessing the damages payable in favour of the plaintiffs pursuant to the formulae<br />

set out in the amendments, the court hearing the matter is next required to determine<br />

the portion of those damages that corresponds to each defendant’s respective<br />

responsibility for the damages. Thus, it would be expected that the court would assign<br />

a percentage of liability to each defendant found liable.<br />

Consequently, the amendments contemplate that each defendant would be required<br />

only to pay up to that portion of the plaintiffs’ aggregate damage award fixed by the<br />

judge, subject to the further liability limits discussed below.<br />

This constitutes a departure from the concept of joint and several liability usually<br />

applied by judges in assessing damages at common law. A judge typically fixes the<br />

relative proportion of liability for each defendant. He or she also normally allows the<br />

plaintiff to recover the full amount of the plaintiffs’ aggregate damage award from any<br />

of the defendants, thereby exposing each defendant found liable to any degree to the<br />

risk that it will have to pay the entire judgment and then seek to recover the<br />

contribution of their respective shares from other co-defendants. In the event that<br />

some of the defendants found liable are not creditworthy, the “deep pocket” defendant<br />

can be left exposed to pay amounts well in excess of its share.<br />

This “proportionate liability” limitation on defendants’ liability to pay the<br />

aggregate amount of damages assessed in favour of the plaintiffs will not be<br />

available to any defendant, other than the responsible issuer, that “authorized,<br />

permitted or acquiesced in the making of the misrepresentation or the failure to<br />

make timely disclosure of a material change”. Such a defendant would be liable<br />

to pay the full amount of damages assessed in favour of the plaintiff, as calculated by<br />

the formulae. In such circumstances, the paying defendant may seek to recover a<br />

contribution from the other defendants in accordance with their respective shares<br />

of liability and subject to their individual liability limits discussed below.<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

23


2.4.3 Limiting damages<br />

In addition to the limitations inherent in the formulae and the fixing of proportionate<br />

liability discussed above, damages available pursuant to the new statutory rights of action as<br />

against individual defendants are, absent knowledge, subject to specific liability limits.<br />

The amendments do not limit or affect damages that might be available under common<br />

law claims, nor do they purport to affect the application of joint and several liability<br />

with respect to such claims.<br />

WHERE THERE WAS NO KNOWLEDGE<br />

Absent knowledge on the part of a defendant of the misrepresentation or failure to<br />

make timely disclosure of a material change (at the time of the misrepresentation or<br />

failure to make timely disclosure), the following liability limits apply with respect to the<br />

new statutory rights of action:<br />

• for a responsible issuer or an influential person who is not an individual, the<br />

greater of 5% of the responsible issuer’s market capitalization and $1 million;<br />

• for directors and officers of responsible issuers and influential persons who are<br />

individuals, the greater of $25,000 and 50% of the prior 12 months’ compensation<br />

received by them from the responsible issuer and its affiliates;<br />

• for directors and officers of an influential person, the greater of $25,000<br />

and 50% of the prior 12 months’ compensation received from the influential person<br />

and its affiliates;<br />

• for persons that made public oral statements with actual, implied or apparent<br />

authority that attracted liability (excluding the responsible issuer, its directors and<br />

officers, influential persons, directors and officers of influential persons or experts)<br />

the greater of $25,000 and 50% of the prior 12 months’ compensation received from<br />

the responsible issuer and its affiliates; and<br />

• for experts, the greater of $1,000,000 and the prior 12 months’ revenues received<br />

from the issuer and its affiliates.<br />

These limits are set out in chart form in Appendix E.<br />

WHERE THERE WAS KNOWLEDGE<br />

If the plaintiff can establish knowledge of either the misrepresentation or failure to<br />

make disclosure of a material change by a defendant, these caps on damages cease to<br />

be available.<br />

PRECAUTIONS<br />

Because the extent of damages that can be recovered will in many cases depend on<br />

whether knowledge can be established, it can be expected that a disproportionate<br />

number of proceedings will be commenced with allegations that at least some of<br />

the defendants knowingly breached their disclosure obligations. Therefore, at all<br />

24 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


stages of the proceeding, including at the application for leave to commence the<br />

proceeding, a key evidentiary issue will be the subjective knowledge of the named<br />

defendants. Individual defendants may need separate counsel, and may be able to<br />

greatly enhance their positions on this key issue by the precautions of taking notes<br />

and maintaining files with respect to their involvement with the issuer. In addition,<br />

draft minutes for meetings attended should be reviewed in detail when circulated<br />

and clarifications should be suggested in writing on a timely basis.<br />

2.5 Oversight of statutory claims<br />

In the United States, the availability of class proceedings on behalf of secondary market investors<br />

has encouraged what are sometimes called strike suits. A strike suit typically takes the form of a<br />

class proceeding commenced strategically at the drop of an issuer’s stock price with a view to<br />

“economic intimidation”. It is intended to compel the issuer into a quick settlement.<br />

The amendments have been drafted with a view to curtailing the risk of a proliferation of<br />

strike suits in Ontario. The following provisions reflect this:<br />

• The plaintiff can commence a proceeding only with leave of the court.<br />

• The court will grant permission only if the plaintiff satisfies it that<br />

– the action is being brought in good faith, and<br />

– there is a reasonable possibility that the plaintiff will succeed.<br />

• The leave hearing to commence a proceeding will thus involve the consideration of affidavit<br />

evidence from both the plaintiffs and the defendants as part of a preliminary merits test.<br />

• Parties who swear affidavits in support of their position on the motion for leave to commence a<br />

proceeding may be cross-examined.<br />

• The costs of bringing a motion for leave to commence a proceeding, including the<br />

potentially burdensome costs of extensive cross-examinations, may act as a partial check<br />

against frivolous claims.<br />

• The court has the power to award costs against an unsuccessful plaintiff (although the amount<br />

of these costs remains at the court’s discretion).<br />

• The court must approve any settlement reached or discontinuance, as appropriate in the<br />

circumstances.<br />

• The plaintiff must notify the OSC at each stage and the OSC will have opportunities to<br />

intervene. For example:<br />

– a copy of the application for leave to proceed and any supporting affidavits must be<br />

filed with the OSC at the time application is filed with court,<br />

– if leave is granted to proceed, the plaintiff must issue a press release and file it with<br />

the OSC, and<br />

– the plaintiff must file the statement of claim with the OSC when it is filed with<br />

the court.<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

25


3<br />

THE<br />

OSC’S NEW POWERS:<br />

New offences, tougher sanctions<br />

In addition to the creation of the statutory rights of action described above, the amendments<br />

create additional offences under the Securities Act which may be prosecuted by the OSC and<br />

increase the availability of sanctions for non-compliance with the Securities Act.<br />

3.1 Overview of enforcement alternatives<br />

3.1.1 Penalties and disgorgement<br />

In its mandate to enforce requirements of the Securities Act and to protect the integrity of<br />

the capital markets, the OSC has at least three distinct enforcement routes:<br />

• Section 122: gives the Ontario Court of Justice a quasi-criminal jurisdiction to consider<br />

offences under the Securities Act;<br />

• Section 127: the OSC enforcement staff’s most commonly used enforcement route,<br />

which provides an OSC panel with administrative jurisdiction to conduct hearings and<br />

make determinations regarding non-compliance with the Securities Act as well as a variety<br />

of remedies; and<br />

• Section 128: the least-used enforcement route, which allows OSC enforcement staff to<br />

bring a quasi-civil proceeding before the Ontario Court of Justice seeking a declaration<br />

that there has been a breach of securities law.<br />

In addition to the enforcement remedies contained in the Securities Act, the Criminal Code<br />

contains provisions that are available in serious cases to prosecute wrongdoers for such<br />

crimes as conspiracy, market manipulation and fraud. 1<br />

3.1.2 Violations recognized prior to the amendments<br />

Prior to the amendments, s. 122 proceedings could be commenced for the offences of:<br />

• making a materially misleading or untrue statement to the OSC or to staff of the OSC,<br />

• making materially misleading or untrue statements in documents required to be<br />

furnished or filed under Ontario securities law with the OSC, or<br />

• contravening Ontario securities law (the “basket clause”).<br />

Prior to the amendments, s. 127 allowed the OSC to make orders where a person or<br />

company was found to have either:<br />

• failed to comply with Ontario securities law; or<br />

• acted in a manner inconsistent with the public interest (even though he, she or it had<br />

complied with Ontario securities law).<br />

Prior to the amendments, s. 128 allowed the OSC to apply to the Court for a declaration<br />

that a person or company has not, or is not, complying with Ontario securities law.<br />

1<br />

Criminal Code, ss. 380(1), 380(2) and 382.<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

27


3.1.3 New violations<br />

The amendments give the OSC three new express violations on which to base a<br />

prosecution before the court under s. 122 or s. 128, or a proceeding before the<br />

Commission under s. 127:<br />

• making a materially misleading or untrue statement that would reasonably be<br />

expected to have a significant effect on the market price or value of a security;<br />

• market manipulation; or<br />

• securities fraud.<br />

Prior to these amendments, which came into force April 7, 2003, most s. 127 enforcement<br />

proceedings involving the conduct specifically caught by the new offences might have been<br />

proceeded with under the OSC’s general jurisdiction to remedy misconduct that was<br />

contrary to the public interest, or potentially for violating the law or making a misleading or<br />

untrue statement in a filed document or to the OSC.<br />

3.1.4 Making a misleading or untrue statement<br />

THE PROVISION (s. 126.2)<br />

Under this new provision, it is an offence for a person or company to make a statement<br />

that the person or company knows or reasonably ought to know:<br />

• is misleading or untrue or is missing a fact that is required to be stated or that is<br />

necessary to make the statement not misleading; and<br />

• would reasonably be expected to have a significant effect on the market price or value<br />

of a security.<br />

Section 126.2 applies to all statements, whether written or oral.<br />

DIRECTORS’ AND OFFICERS’ OFFENCES<br />

Where an issuer is alleged to have made a misleading or untrue statement, any director<br />

or officer who authorized, permitted or acquiesced in the making of the statement may<br />

be the subject of proceedings, whether or not any proceeding has been commenced<br />

against the company.<br />

3.1.5 Market manipulation<br />

THE PROVISION (s. 126.1 (a))<br />

It is an offence under this new provision for a person or company to “directly or<br />

indirectly, engage or participate in any act, practice or course of conduct relating to<br />

securities or derivatives of securities that the person or company knows or reasonably<br />

ought to know results in or contributes to a misleading appearance of trading activity<br />

in, or an artificial price for, a security or derivative of a security”.<br />

28 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


DIRECTORS’ AND OFFICERS’ OFFENCES<br />

Where an issuer has committed the offence of market manipulation, any director or<br />

officer who has authorized, permitted or acquiesced in that conduct may also be held<br />

liable, whether or not any proceeding has been commenced against the company.<br />

3.1.6 Fraud<br />

THE PROVISION (s. 126.1 (b))<br />

It is a violation of this new provision for a person or company to “directly or indirectly,<br />

engage or participate in any act, practice or course of conduct relating to securities or<br />

derivatives of securities that the person or company knows or reasonably ought to know<br />

perpetrates a fraud on any person or company”.<br />

PROVING CLAIMS<br />

Unlike the typical criminal standard for proving fraud, the fraud offence requires only<br />

that the respondent/accused have performed some act “either directly or indirectly” that<br />

he or she knows or reasonably ought to have known would dishonestly negatively<br />

impact another person.<br />

This means that a party may be guilty of “fraud” even though it had not known that<br />

the conduct in question was fraudulent. This negligent fraud concept is unusual and<br />

appears to depart from the common law requirement that an individual must have<br />

knowledge of the wrongdoing for a finding of fraud.<br />

DIRECTORS’ AND OFFICERS’ OFFENCES<br />

Where an issuer has committed the offence of fraud, any director or officer who has<br />

authorized, permitted or acquiesced in that conduct may also be held liable, whether or<br />

not any proceeding has been commenced against the company.<br />

3.2 Section 127 enforcement sanctions<br />

3.2.1 Prior to the amendments<br />

Prior to the amendments, the sanctions under a s. 127 proceeding included prohibiting<br />

a respondent from:<br />

• trading in securities in Ontario;<br />

• acting as a director or officer of a corporation in Ontario; or<br />

• being registered to trade in or give advice with respect to the trading of securities in Ontario.<br />

An unsuccessful respondent in a s. 127 proceeding could also be:<br />

• reprimanded;<br />

• ordered to resign their position as officer or director of an issuer; and<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

29


• ordered to pay the OSC’s costs of the investigation and the costs of or<br />

related to the hearing.<br />

3.2.2 New sanctions<br />

The amendments also give the OSC two new administrative sanctions under a<br />

s. 127 proceeding. It may:<br />

• levy an “administrative penalty” of up to $1 million (for each violation of securities<br />

law); and<br />

• order the disgorgement of profits made as a result of a violation of securities law.<br />

The amendments, which came into force April 7, 2003, give the Minister of Finance<br />

of Ontario the right to establish guidelines respecting the allocation of money received<br />

by the OSC under these sanctions or pursuant to settlement agreements arrived at with<br />

the Commission.<br />

3.2.3 Penalties and disgorgement<br />

Fines and disgorgement are not, strictly speaking, new sanctions. There is a history of<br />

settlement agreements between OSC enforcement staff and respondents that have<br />

resulted in orders of this sort. What is new is the OSC’s authority to impose fines or<br />

disgorgement in the absence of a settlement agreement.<br />

3.3 Section 122 quasi-criminal enforcement sanctions<br />

Under s. 122 of the Securities Act, the OSC can assume the role of prosecutor and has the<br />

authority to charge a person or company contravening Ontario securities law with an offence that<br />

is prosecuted before the provincial courts pursuant to the Provincial Offences Act. A finding of guilt<br />

under s. 122 can lead to a penalty of imprisonment. The prerequisite for a s. 122 proceeding is<br />

that there must have been an express breach of an Ontario securities laws. It is not sufficient<br />

for there to have been “conduct contrary to the public interest”.<br />

Under a s. 122 proceeding, the amended court sanctions include:<br />

• a maximum court-imposed fine of up to $5 million; and/or<br />

• a maximum jail term of five years less a day (which is, notably, one day short of the time<br />

required for the constitutional protections of a jury trial).<br />

Section 127 proceedings are significantly more common than s. 122 prosecutions because<br />

findings of securities law breaches are likely easier to obtain for OSC staff in an administrative<br />

setting (with a lower burden of proof) than in the quasi-criminal setting of a s. 122 proceeding.<br />

30 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


4 TIPS:<br />

Preventive medicine, new rules and responding to litigation<br />

4.1 Issuers<br />

On April 7, 2003, rule-making authority was conferred on the OSC with respect to the<br />

establishment of various Sarbanes-Oxley-type standards and procedures, and the OSC was<br />

also granted the power to initiate reviews of continuous disclosure practices.<br />

The OSC has released for public comment some “made in Canada” Sarbanes-Oxley-type<br />

standards and procedures. These standards and procedures propose to:<br />

• require fully independent audit committees, with their composition, qualifications (including<br />

financial literacy) and responsibilities prescribed by the OSC;<br />

• require audit firms to be members in good standing of the new Canadian Public<br />

Accountability Board; and<br />

• require certification from the CEO and CFO with respect to annual and interim financial<br />

statements and other filings, as well as with respect to the reasonableness of internal controls.<br />

For further information, see Appendix F.<br />

The new statutory rights of action created by the amendments are subject to a number of<br />

defences. Public companies and those associated with them can enhance the possibility that they<br />

will be able to rely on these defences by adopting and carefully following individually designed<br />

compliance procedures, in addition to those needed to make the certifications that will now be<br />

required by law. Of course, improved compliance will also make litigation less likely, thus<br />

creating a “virtuous circle”.<br />

Compliance procedures may include the steps outlined in the following paragraphs.<br />

CORPORATE DISCLOSURE POLICY<br />

Each public company should establish, or review and enhance, a corporate disclosure policy<br />

to provide a process for disclosure and promote an understanding of the legal requirements<br />

among its directors, officers and employees. The policy should:<br />

• be practical and individually tailored;<br />

• be regularly updated;<br />

• comply with National Policy 51-201 of the Canadian Securities Regulators; and<br />

• address the following matters:<br />

– materiality decisions,<br />

– analysts’ reports,<br />

– earnings announcements,<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

31


– analyst calls and meetings,<br />

– prohibiting selective disclosure,<br />

– the use of electronic media (including e-mail, chat rooms and bulletin boards),<br />

– postings on the corporate website,<br />

– the use of forward–looking information,<br />

– the involvement of the board and/or board committees,<br />

– dealing with unintentional selective disclosure,<br />

– reacting to rumours,<br />

– authorized spokespersons,<br />

– “quiet periods”, and<br />

– unless covered in the insider trading policy, trading restrictions.<br />

In addition, educational seminars may be desirable.<br />

DISCLOSURE COMPLIANCE SYSTEM<br />

Each public company should review and improve, or develop, a disclosure compliance system<br />

and procedures designed to seek to ensure that material information concerning the company’s<br />

affairs is brought to the attention of those in charge of its public disclosure. These procedures<br />

should seek to ensure the correctness of disclosure documents, as well as press releases, website<br />

postings and other corporate disclosures, including speeches and other oral presentations. These<br />

procedures may include, for example:<br />

• questionnaires;<br />

• due diligence sessions;<br />

• internal certification requirements;<br />

• de-briefings;<br />

• involvement of or review by experienced legal counsel;<br />

• the involvement of a board-level disclosure committee;<br />

• circulation to directors of all disclosures; and<br />

• the investigation of allegations made by “whistle-blowers”.<br />

Procedures will vary substantially by issuer, to reflect each issuer’s operations, and should be as<br />

practical as possible. In many cases, there may be procedures already in place, but they may not<br />

have been documented. Among other things, all significant proposed acquisitions, restructurings<br />

or dispositions, as well as other material corporate decisions, intellectual property developments,<br />

changes in union relationships, legal proceedings, and signings or terminations of significant<br />

contracts should be reviewed, perhaps more rigorously than in the past, for disclosure purposes.<br />

This may perhaps lead to more frequent confidential material change reports at an earlier stage.<br />

Again, education and training may be desirable.<br />

32 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


Disclosure procedures should strive to:<br />

• familiarize company personnel with material change reports and the confidential material<br />

change report process, which may be used substantially more now than has been the case in<br />

the past;<br />

• develop or improve the process for enabling officers and directors to notify the board<br />

promptly so as to facilitate quick corrective action to rectify incorrect disclosure as soon as<br />

possible, so as to minimize both personal and corporate liability;<br />

• institute a process for dealing with forward-looking information of all types, so as to seek to<br />

ensure that it is reasonably based and contains appropriate cautionary language and key<br />

assumptions;<br />

• formalize procedures to improve management’s discussion and analysis in response to recent<br />

regulatory and other developments, and to deal with non-GAAP financial measures such as<br />

EBITDA and cash available for distribution (especially in the case of REITs, royalty trusts<br />

and income funds), etc.;<br />

• define the roles and responsibilities of directors and committees by setting out “charters” or<br />

mandates, which should be carefully designed to satisfy required obligations while seeking to<br />

avoid increasing liability; and<br />

• develop a process to review expert reports that are to be relied upon, including those of<br />

auditors, tax advisors, actuaries, engineers or geologists.<br />

All procedures, if developed, should be complied with, or else you may be worse off<br />

than if you had not developed them. That is why they need to be practical and achievable<br />

for your organization.<br />

INSIDER TRADING POLICIES<br />

Public companies should re-assess and update their insider trading policies to seek to ensure<br />

compliance with insider trading restrictions and proper reporting of insider transactions,<br />

especially in light of the new Internet-based SEDI procedures.<br />

4.2 Directors and officers<br />

Directors and officers can further protect themselves against potential liability for breach of<br />

continuous disclosure obligations by being duly diligent, including by:<br />

• asking individuals who are responsible for ensuring compliance with continuous disclosure<br />

requirements about the steps they have taken to ensure the accuracy of information contained<br />

in documents to be disclosed or statements to be made public;<br />

• dealing with complaints as they happen and overseeing any investigation where it appears that<br />

controls have failed;<br />

• streamlining and scripting public oral statements to protect against inadvertent<br />

misrepresentations;<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

33


• having counsel review the existing D&O liability insurance policy for adequacy of coverage<br />

with respect to personal liability of directors and officers, seeking to ensure that:<br />

– directors and officers are entitled to select counsel under the terms of the policy,<br />

– directors’ and officers’ legal and other costs in defending a claim are covered by the<br />

policy and that these costs are advanced by the insurer during the defence of the<br />

action, and<br />

– coverage is afforded to “innocent” officers and directors in circumstances where<br />

allegations of fraud or intentional wrongdoing are levelled against the reporting<br />

issuer and only certain of its officers and directors;<br />

• retaining counsel to provide independent legal advice on issues as the circumstances require;<br />

• reviewing and, if necessary, correcting minutes of meetings; and<br />

• taking notes and maintaining files with respect to their involvement with the issuer at all<br />

stages of the proceeding commenced under the statutory liability regime, including at the<br />

application for leave to commence the proceeding, a key evidentiary issue will be the<br />

subjective knowledge of the named defendants. Individual defendants may be able to greatly<br />

enhance their positions on this key issue if they maintain appropriate records.<br />

4.3 Auditors<br />

Auditors can seek to reduce the likelihood of attracting liability by complying with the<br />

standards articulated by their professional regulatory bodies. The Canadian Institute of<br />

Chartered Accountants has included a new section in its Handbook entitled “The Auditor’s<br />

Responsibility to Consider Fraud and Error in an Audit of Financial Statements”. The section<br />

details new procedural requirements, including the following:<br />

• to ask management about its assessment of the risk that the financial statements may be<br />

materially misstated as a result of fraud, about controls they have implemented, and whether<br />

they are aware of any fraud, suspected fraud or material errors;<br />

• to consider whether matters relating to internal controls should be discussed with the audit<br />

committee at the planning stage of the audit;<br />

• when assessing inherent and control risks, to assess how the financial statements might be<br />

materially misstated as a result of fraud or error (the new standard also requires the auditor, as<br />

part of the risk assessment, to consider whether fraud risk factors are present);<br />

• if fraud risk factors are identified as being present, to address them when designing audit<br />

procedures (the identified factors, and the auditor’s responses, should be documented); and<br />

• to obtain additional written representations from the appropriate level of management,<br />

including:<br />

– that management has disclosed to the auditor all significant facts relating to any<br />

frauds or suspected frauds, and<br />

– that management believes the effects of unadjusted errors accumulated by the<br />

auditor are immaterial, both individually and in the aggregate.<br />

34 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


4.4 Establishing defences<br />

Proper compliance with disclosure obligations will not necessarily prevent the initiation of<br />

litigation, but demonstrated and clearly documented compliance procedures, if complied with,<br />

are likely to go a long way towards establishing the defences discussed above.<br />

4.5 Responding to a formal or informal threat of litigation<br />

In the face of a formal or informal threat of litigation, it is imperative that immediate steps be<br />

taken to ensure that the appropriate response is prepared and that, where appropriate, remedial<br />

or protective steps are taken.<br />

The immediate next steps which we recommend in the face of any threat of litigation<br />

are as follows:<br />

• Notify the whole board of directors of the claim asserted;<br />

• Review the risk management issues and make timely notification to liability insurers<br />

(for issuer, directors and officers);<br />

• Consider whether a press release and/or material change report are appropriate<br />

or required;<br />

• Consider whether any regulatory compliance requirement is triggered;<br />

• Ensure that documents which may be relevant are collected and not destroyed<br />

(despite the company’s document retention policy, if any);<br />

• Notify outside counsel where appropriate to obtain objective advice regarding<br />

immediate steps; and<br />

• Assess whether separate counsel are required for some or all defendants.<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

35


5 CONCLUSION<br />

Whether, by allowing for greater regulatory oversight and investor-driven enforcement through<br />

new statutory rights of action, the amendments will in the long run encourage diligence at the<br />

boardroom table, more stringent management oversight and increased confidence in our capital<br />

markets is impossible to know at this stage. However, it is unlikely that the basic human foibles<br />

that create the environment for financial statement manipulation, insider trading, market<br />

manipulation, misrepresentation and their ilk will disappear by government fiat, or at all. If<br />

care is not taken, however, there are now substantially greater opportunities for shareholder<br />

lawsuits to be brought and to succeed.<br />

As for the statutory civil liability regime, we can say with some confidence that one of the best<br />

defences to a shareholder lawsuit may well be the demonstration of efforts to meet the demands<br />

of this increased regulatory oversight through the implementation of procedures and standards<br />

that are designed to prevent misrepresentations and failures to make timely disclosure.<br />

<strong>Stikeman</strong> <strong>Elliott</strong> LLP’s corporate governance team has extensive experience in this area and can<br />

help directors, officers and public companies respond to the challenges the amendments create, by:<br />

• presenting educational and training seminars at the location of your choice to the<br />

audience of your choosing. Whether it be a board of directors, a group of senior executives,<br />

or your regulatory compliance personnel, we can provide specific guidance relevant to<br />

your circumstances;<br />

• providing legal advice to public companies and individuals (including “second opinions”);<br />

• vetting corporate governance and compliance procedures, in order to identify potential<br />

weaknesses and recommend practical improvements;<br />

• recommending new compliance and corporate governance procedures tailored to your<br />

business environment; and<br />

• assisting (on an “outsourced” basis) with ensuring adherence to newly adopted procedures<br />

(e.g. insider reporting).<br />

We recommend proactive use of our seminars and consultations, in the short term, as a means of<br />

reducing the likelihood that it will later prove necessary to hire outside counsel to defend an action.<br />

However, if regulatory proceedings or litigation threaten, our experienced team of securities and<br />

class action litigators is one of the best allies you can have.<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

37


Full Text of the Major Amendments<br />

APPENDIX<br />

A


A<br />

Major amendments to the Securities Act (Ontario)<br />

This appendix includes the full text of two major additions to the Securities Act under the Bill 198 and Bill 41 amendments.<br />

These are (i) the new offences relating to fraud, market manipulation and misleading or untrue statements (sections 126.1 and<br />

126.2) and (ii) the sections establishing civil liability under the Act for secondary market disclosure (collectively, Part XXIII.1).<br />

It is important to note that at the time of writing none of these sections have been proclaimed in force. The text below<br />

reflects Bill 198 as we anticipate it will be amended by Bill 41. However, as Bill 41 has not yet been passed by the Ontario<br />

legislature, we caution readers that it is possible that the final version of the legislation will differ from what appears below.<br />

■ Section 126.1<br />

Fraud and market manipulation<br />

126.1 A person or company shall not, directly or indirectly, engage or participate in any act, practice or course of conduct<br />

relating to securities or derivatives of securities that the person or company knows or reasonably ought to know,<br />

(a) results in or contributes to a misleading appearance of trading activity in, or an artificial price for, a security or<br />

derivative of a security; or<br />

(b) perpetrates a fraud on any person or company.<br />

Section 126.2<br />

Misleading or untrue statements<br />

126.2 (1) A person or company shall not make a statement that the person or company knows or reasonably ought to know,<br />

(a) in a material respect and at the time and in the light of the circumstances under which it is made, is misleading or untrue<br />

or does not state a fact that is required to be stated or that is necessary to make the statement not misleading; and<br />

(b) would reasonably be expected to have a significant effect on the market price or value of a security.<br />

(2) A breach of subsection (1) does not give rise to a statutory right of action for damages otherwise than under<br />

Part XXIII or XXIII.1.<br />

■ Part XXIII.1<br />

Civil Liability for Secondary Market Disclosure<br />

INTERPRETATION AND APPLICATION<br />

Definitions<br />

138.1 In this Part,<br />

“compensation” means compensation received during the 12-month period immediately preceding the day on which the<br />

misrepresentation was made or on which the failure to make timely disclosure first occurred, together with the fair market<br />

value of all deferred compensation including, without limitation, options, pension benefits and stock appreciation rights,<br />

granted during the same period, valued as of the date that such compensation is awarded; (“rémunération”)<br />

“control person” means,<br />

(a) a person or company who holds a sufficient number of the voting rights attached to all outstanding voting<br />

securities of an issuer, or<br />

(b) each person or company or combination of persons or companies acting in concert by virtue of an agreement,<br />

arrangement, commitment or understanding, which holds in total a sufficient number of the voting rights attached to<br />

all outstanding voting securities of an issuer,<br />

to affect materially the control of the issuer, and, where a person or company, or combination of persons or companies, holds<br />

more than 20 per cent of the voting rights attached to all outstanding voting securities of an issuer, the person or company, or<br />

combination of persons or companies, shall, in the absence of evidence to the contrary, be deemed to hold a sufficient number<br />

of the voting rights to affect materially the control of the issuer; (“personne qui a le contrôle”)<br />

40 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


A<br />

“core document” means,<br />

(a) where used in relation to,<br />

(i) a director of a responsible issuer who is not also an officer of the responsible issuer,<br />

(ii) an influential person, other than an officer of the responsible issuer or an investment fund manager where the<br />

responsible issuer is an investment fund, or<br />

(iii) a director or officer of an influential person who is not also an officer of the responsible issuer, other than an<br />

officer of an investment fund manager,<br />

a prospectus, a take-over bid circular, an issuer bid circular, a directors’ circular, a rights offering circular, management’s<br />

discussion and analysis, an annual information form, an information circular, annual financial statements and interim financial<br />

statements of the responsible issuer,<br />

(b) where used in relation to,<br />

(i) a responsible issuer or an officer of the responsible issuer,<br />

(ii) an investment fund manager, where the responsible issuer is an investment fund, or<br />

(iii) an officer of an investment fund manager, where the responsible issuer is an investment fund,<br />

a prospectus, a take-over bid circular, an issuer bid circular, a directors’ circular, a rights offering circular, management’s<br />

discussion and analysis, an annual information form, an information circular, annual financial statements, interim financial<br />

statements and a report required by subsection 75 (2) of the responsible issuer, and<br />

(c) such other documents as may be prescribed by regulation for the purposes of this definition; (“document essentiel”)<br />

“document” means any written communication, including a communication prepared and transmitted only in electronic form,<br />

(a) that is required to be filed with the Commission, or<br />

(b) that is not required to be filed with the Commission and,<br />

(i) that is filed with the Commission,<br />

(ii) that is filed or required to be filed with a government or an agency of a government under applicable securities or<br />

corporate law or with any stock exchange or quotation and trade reporting system under its by-laws, rules or regulations, or<br />

(iii) that is any other communication the content of which would reasonably be expected to affect the market price<br />

or value of a security of the responsible issuer; (“document”)<br />

“expert” means a person or company whose profession gives authority to a statement made in a professional capacity by the<br />

person or company including, without limitation, an accountant, actuary, appraiser, auditor, engineer, financial analyst,<br />

geologist or lawyer; (“expert”)<br />

“failure to make timely disclosure” means a failure to disclose a material change in the manner and at the time required under<br />

this Act; (“non-respect des obligations d’information occasionnelle”)<br />

“influential person” means, in respect of a responsible issuer,<br />

(a) a control person,<br />

(b) a promoter,<br />

(c) an insider who is not a director or senior officer of the responsible issuer, or<br />

(d) an investment fund manager, if the responsible issuer is an investment fund; (“personne influente”)<br />

“issuer’s security” means a security of a responsible issuer and includes a security,<br />

(a) the market price or value of which, or payment obligations under which, are derived from or based on a security<br />

of the responsible issuer, and<br />

(b) which is created by a person or company on behalf of the responsible issuer or is guaranteed by the responsible<br />

issuer; (“valeur mobilière d’un émetteur”)<br />

“liability limit” means,<br />

(a) in the case of a responsible issuer, the greater of,<br />

(i) 5 per cent of its market capitalization (as such term is defined in the regulations), and<br />

(ii) $1 million,<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

41


A<br />

(b) in the case of a director or officer of a responsible issuer, the greater of,<br />

(i) $25,000, and<br />

(ii) 50 per cent of the aggregate of the director’s or officer’s compensation from the responsible issuer and its affiliates,<br />

(c) in the case of an influential person who is not an individual, the greater of,<br />

(i) 5 per cent of its market capitalization (as defined in the regulations), and<br />

(ii) $1 million,<br />

(d) in the case of an influential person who is an individual, the greater of,<br />

(i) $25,000, and<br />

(ii) 50 per cent of the aggregate of the influential person’s compensation from the responsible issuer and its affiliates,<br />

(e) in the case of a director or officer of an influential person, the greater of,<br />

(i) $25,000, and<br />

(ii) 50 per cent of the aggregate of the director’s or officer’s compensation from the influential person and its affiliates,<br />

(f) in the case of an expert, the greater of,<br />

(i) $1 million, and<br />

(ii) the revenue that the expert and the affiliates of the expert have earned from the responsible issuer and its<br />

affiliates during the 12 months preceding the misrepresentation, and<br />

(g) in the case of each person who made a public oral statement, other than an individual referred to in clause (d), (e)<br />

or (f), the greater of,<br />

(i) $25,000, and<br />

(ii) 50 per cent of the aggregate of the person’s compensation from the responsible issuer and its affiliates; (“limite<br />

de responsabilité”)<br />

“management’s discussion and analysis” means the section of an annual information form, annual report or other document<br />

that contains management’s discussion and analysis of the financial condition and results of operations of a responsible issuer<br />

as required under Ontario securities law; (“rapport de gestion”)<br />

“public oral statement” means an oral statement made in circumstances in which a reasonable person would believe that<br />

information contained in the statement will become generally disclosed; (“déclaration orale publique”)<br />

“release” means, with respect to information or a document, to file with the Commission or any other securities regulatory<br />

authority in Canada or a stock exchange or to otherwise make available to the public; (“publication”, “publier”)<br />

“responsible issuer” means,<br />

(a) a reporting issuer, or<br />

(b) any other issuer with a real and substantial connection to Ontario, any securities of which are publicly traded;<br />

(“émetteur responsable”)<br />

“trading day” means a day during which the principal market (as defined in the regulations) for the security is open for trading.<br />

(“jour de Bourse”)<br />

Application<br />

138.2 This Part does not apply to,<br />

(a) the purchase of a security offered by a prospectus during the period of distribution;<br />

(b) the acquisition of an issuer’s security pursuant to a distribution that is exempt from section 53 or 62, except as may<br />

be prescribed by regulation;<br />

(c) the acquisition or disposition of an issuer’s security in connection with or pursuant to a take-over bid or issuer bid,<br />

except as may be prescribed by regulation; or<br />

(d) such other transactions or class of transactions as may be prescribed by regulation.<br />

42 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


A<br />

LIABILITY<br />

Liability for secondary market disclosure: Documents released by responsible issuer<br />

138.3 (1) Where a responsible issuer or a person or company with actual, implied or apparent authority to act on behalf of<br />

a responsible issuer releases a document that contains a misrepresentation, a person or company who acquires or disposes of<br />

the issuer’s security during the period between the time when the document was released and the time when the<br />

misrepresentation contained in the document was publicly corrected has, without regard to whether the person or company<br />

relied on the misrepresentation, a right of action for damages against,<br />

(a) the responsible issuer;<br />

(b) each director of the responsible issuer at the time the document was released;<br />

(c) each officer of the responsible issuer who authorized, permitted or acquiesced in the release of the document;<br />

(d) each influential person, and each director and officer of an influential person, who knowingly influenced,<br />

(i) the responsible issuer or any person or company acting on behalf of the responsible issuer to release the document, or<br />

(ii) a director or officer of the responsible issuer to authorize, permit or acquiesce in the release of the document; and<br />

(e) each expert where,<br />

(i) the misrepresentation is also contained in a report, statement or opinion made by the expert,<br />

(ii) the document includes, summarizes or quotes from the report, statement or opinion of the expert, and<br />

(iii) if the document was released by a person or company other than the expert, the expert consented in writing<br />

to the use of the report, statement or opinion in the document.<br />

Public oral statements by responsible issuer<br />

(2) Where a person with actual, implied or apparent authority to speak on behalf of a responsible issuer makes a public<br />

oral statement that relates to the business or affairs of the responsible issuer and that contains a misrepresentation, a<br />

person or company who acquires or disposes of the issuer’s security during the period between the time when the public<br />

oral statement was made and the time when the misrepresentation contained in the public oral statement was publicly<br />

corrected has, without regard to whether the person or company relied on the misrepresentation, a right of action for<br />

damages against,<br />

(a) the responsible issuer;<br />

(b) the person who made the public oral statement;<br />

(c) each director and officer of the responsible issuer who authorized, permitted or acquiesced in the making of the<br />

public oral statement;<br />

(d) each influential person, and each director and officer of the influential person, who knowingly influenced,<br />

(i) the person who made the public oral statement to make the public oral statement, or<br />

(ii) a director or officer of the responsible issuer to authorize, permit or acquiesce in the making of the public oral<br />

statement; and<br />

(e) each expert where,<br />

(i) the misrepresentation is also contained in a report, statement or opinion made by the expert,<br />

(ii) the person making the public oral statement includes, summarizes or quotes from the report, statement or<br />

opinion of the expert, and<br />

(iii) if the public oral statement was made by a person other than the expert, the expert consented in writing to<br />

the use of the report, statement or opinion in the public oral statement.<br />

Influential persons<br />

(3) Where an influential person or a person or company with actual, implied or apparent authority to act or speak on<br />

behalf of the influential person releases a document or makes a public oral statement that relates to a responsible issuer and<br />

that contains a misrepresentation, a person or company who acquires or disposes of the issuer’s security during the period<br />

between the time when the document was released or the public oral statement was made and the time when the<br />

misrepresentation contained in the document or public oral statement was publicly corrected has, without regard to whether<br />

the person or company relied on the misrepresentation, a right of action for damages against,<br />

(a) the responsible issuer, if a director or officer of the responsible issuer, or where the responsible issuer is an<br />

investment fund, the investment fund manager, authorized, permitted or acquiesced in the release of the document or<br />

the making of the public oral statement;<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

43


A<br />

(b) the person who made the public oral statement;<br />

(c) each director and officer of the responsible issuer who authorized, permitted or acquiesced in the release of the<br />

document or the making of the public oral statement;<br />

(d) the influential person;<br />

(e) each director and officer of the influential person who authorized, permitted or acquiesced in the release of the<br />

document or the making of the public oral statement; and<br />

(f) each expert where,<br />

(i) the misrepresentation is also contained in a report, statement or opinion made by the expert,<br />

(ii) the document or public oral statement includes, summarizes or quotes from the report, statement or opinion<br />

of the expert, and<br />

(iii) if the document was released or the public oral statement was made by a person other than the expert, the expert<br />

consented in writing to the use of the report, statement or opinion in the document or public oral statement.<br />

Failure to make timely disclosure<br />

(4) Where a responsible issuer fails to make a timely disclosure, a person or company who acquires or disposes of the issuer’s<br />

security between the time when the material change was required to be disclosed in the manner required under this Act and<br />

the subsequent disclosure of the material change has, without regard to whether the person or company relied on the<br />

responsible issuer having complied with its disclosure requirements, a right of action for damages against,<br />

(a) the responsible issuer;<br />

(b) each director and officer of the responsible issuer who authorized, permitted or acquiesced in the failure to make<br />

timely disclosure; and<br />

(c) each influential person, and each director and officer of an influential person, who knowingly influenced,<br />

(i) the responsible issuer or any person or company acting on behalf of the responsible issuer in the failure to<br />

make timely disclosure, or<br />

(ii) a director or officer of the responsible issuer to authorize, permit or acquiesce in the failure to make<br />

timely disclosure.<br />

Multiple roles<br />

(5) In an action under this section, a person who is a director or officer of an influential person is not liable in that capacity<br />

if the person is liable as a director or officer of the responsible issuer.<br />

Multiple misrepresentations<br />

(6) In an action under this section,<br />

(a) multiple misrepresentations having common subject matter or content may, in the discretion of the court, be<br />

treated as a single misrepresentation; and<br />

(b) multiple instances of failure to make timely disclosure of a material change or material changes concerning<br />

common subject matter may, in the discretion of the court, be treated as a single failure to make timely disclosure.<br />

No implied or actual authority<br />

(7) In an action under subsection (2) or (3), if the person who made the public oral statement had apparent authority, but<br />

not implied or actual authority, to speak on behalf of the issuer, no other person is liable with respect to any of the responsible<br />

issuer’s securities that were acquired or disposed of before that other person became, or should reasonably have become, aware<br />

of the misrepresentation.<br />

Burden of proof and defences: Non-core documents and public oral statements<br />

138.4 (1) In an action under section 138.3 in relation to a misrepresentation in a document that is not a core document, or<br />

a misrepresentation in a public oral statement, a person or company is not liable, subject to subsection (2), unless the plaintiff<br />

proves that the person or company,<br />

(a) knew, at the time that the document was released or public oral statement was made, that the document or public<br />

oral statement contained the misrepresentation;<br />

(b) at or before the time that the document was released or public oral statement was made, deliberately avoided<br />

acquiring knowledge that the document or public oral statement contained the misrepresentation; or<br />

44 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


A<br />

(c) was, through action or failure to act, guilty of gross misconduct in connection with the release of the document or<br />

the making of the public oral statement that contained the misrepresentation.<br />

Same<br />

(2) A plaintiff is not required to prove any of the matters set out in subsection (1) in an action under section 138.3 in<br />

relation to an expert.<br />

Failure to make timely disclosure<br />

(3) In an action under section 138.3 in relation to a failure to make timely disclosure, a person or company is not liable,<br />

subject to subsection (4), unless the plaintiff proves that the person or company,<br />

(a) knew, at the time that the failure to make timely disclosure first occurred, of the change and that the change was<br />

a material change;<br />

(b) at the time or before the failure to make timely disclosure first occurred, deliberately avoided acquiring knowledge<br />

of the change or that the change was a material change; or<br />

(c) was, through action or failure to act, guilty of gross misconduct in connection with the failure to make timely disclosure.<br />

Same<br />

(4) A plaintiff is not required to prove any of the matters set out in subsection (3) in an action under section 138.3 in relation to,<br />

(a) a responsible issuer;<br />

(b) an officer of a responsible issuer;<br />

(c) an investment fund manager; or<br />

(d) an officer of an investment fund manager.<br />

Knowledge of the misrepresentation or material change<br />

(5) A person or company is not liable in an action under section 138.3 in relation to a misrepresentation or a failure to<br />

make timely disclosure if that person or company proves that the plaintiff acquired or disposed of the issuer’s security,<br />

(a) with knowledge that the document or public oral statement contained a misrepresentation; or<br />

(b) with knowledge of the material change.<br />

Reasonable investigation<br />

(6) A person or company is not liable in an action under section 138.3 in relation to,<br />

(a) a misrepresentation if that person or company proves that,<br />

(i) before the release of the document or the making of the public oral statement containing the<br />

misrepresentation, the person or company conducted or caused to be conducted a reasonable investigation, and<br />

(ii) at the time of the release of the document or the making of the public oral statement, the person or company<br />

had no reasonable grounds to believe that the document or public oral statement contained the misrepresentation; or<br />

(b) a failure to make timely disclosure if that person or company proves that,<br />

(i) before the failure to make timely disclosure first occurred, the person or company conducted or caused to be<br />

conducted a reasonable investigation, and<br />

(ii) the person or company had no reasonable grounds to believe that the failure to make timely disclosure would occur.<br />

Factors to be considered by court<br />

(7) In determining whether an investigation was reasonable under subsection (6), or whether any person or company is<br />

guilty of gross misconduct under subsection (1) or (3), the court shall consider all relevant circumstances, including,<br />

(a) the nature of the responsible issuer;<br />

(b) the knowledge, experience and function of the person or company;<br />

(c) the office held, if the person was an officer;<br />

(d) the presence or absence of another relationship with the responsible issuer, if the person was a director;<br />

(e) the existence, if any, and the nature of any system designed to ensure that the responsible issuer meets its<br />

continuous disclosure obligations;<br />

(f) the reasonableness of reliance by the person or company on the responsible issuer’s disclosure compliance system<br />

and on the responsible issuer’s officers, employees and others whose duties would in the ordinary course have given<br />

them knowledge of the relevant facts;<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

45


A<br />

(g) the period within which disclosure was required to be made under the applicable law;<br />

(h) in respect of a report, statement or opinion of an expert, any professional standards applicable to the expert;<br />

(i) the extent to which the person or company knew, or should reasonably have known, the content and medium of<br />

dissemination of the document or public oral statement;<br />

(j) in the case of a misrepresentation, the role and responsibility of the person or company in the preparation and<br />

release of the document or the making of the public oral statement containing the misrepresentation or the ascertaining<br />

of the facts contained in that document or public oral statement; and<br />

(k) in the case of a failure to make timely disclosure, the role and responsibility of the person or company involved in<br />

a decision not to disclose the material change.<br />

Confidential disclosure<br />

(8) A person or company is not liable in an action under section 138.3 in respect of a failure to make timely disclosure if,<br />

(a) the person or company proves that the material change was disclosed by the responsible issuer in a report filed on<br />

a confidential basis with the Commission under subsection 75 (3);<br />

(b) the responsible issuer had a reasonable basis for making the disclosure on a confidential basis;<br />

(c) where the information contained in the report filed on a confidential basis remains material, disclosure of the<br />

material change was made public promptly when the basis for confidentiality ceased to exist;<br />

(d) the person or company or responsible issuer did not release a document or make a public oral statement that, due<br />

to the undisclosed material change, contained a misrepresentation; and<br />

(e) where the material change became publicly known in a manner other than the manner required under this Act,<br />

the responsible issuer promptly disclosed the material change in the manner required under this Act.<br />

Forward-looking information<br />

(9) A person or company is not liable in an action under section 138.3 for a misrepresentation in forward-looking<br />

information if the person or company proves all of the following things:<br />

1. The document or public oral statement containing the forward-looking information contained, proximate<br />

to that information,<br />

i. reasonable cautionary language identifying the forward-looking information as such, and identifying material<br />

factors that could cause actual results to differ materially from a conclusion, forecast or projection in the forwardlooking<br />

information, and<br />

ii. a statement of the material factors or assumptions that were applied in drawing a conclusion or making a<br />

forecast or projection set out in the forward-looking information.<br />

2. The person or company had a reasonable basis for drawing the conclusions or making the forecasts and projections<br />

set out in the forward-looking information.<br />

Same<br />

(9.1) The person or company shall be deemed to have satisfied the requirements of paragraph 1 of subsection (9) with respect<br />

to a public oral statement containing forward-looking information if the person who made the public oral statement,<br />

(a) made a cautionary statement that the oral statement contains forward-looking information;<br />

(b) stated that,<br />

(i)the actual results could differ materially from a conclusion, forecast or projection in the forward-looking<br />

information, and<br />

(ii) certain material factors or assumptions were applied in drawing a conclusion or making a forecast or<br />

projection as reflected in the forward-looking information; and<br />

(c) stated that additional information about,<br />

(i)the material factors that could cause actual results to differ materially from the conclusion, forecast or projection<br />

in the forward-looking information, and<br />

(ii) the material factors or assumptions that were applied in drawing a conclusion or making a forecast or projection<br />

as reflected in the forward-looking information,<br />

is contained in a readily-available document or in a portion of such a document and has identified that document or that<br />

portion of the document.<br />

46 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


A<br />

Same<br />

(9.2) For the purposes of clause (9.1) (c), a document filed with the Commission or otherwise generally disclosed shall be<br />

deemed to be readily available.<br />

Exception<br />

(10) Subsection (9) does not relieve a person or company of liability respecting forward-looking information in a financial<br />

statement required to be filed under this Act or forward-looking information in a document released in connection with an<br />

initial public offering.<br />

Expert report, statement or opinion<br />

(11) A person or company, other than an expert, is not liable in an action under section 138.3 with respect to any part of a<br />

document or public oral statement that includes, summarizes or quotes from a report, statement or opinion made by the expert<br />

in respect of which the responsible issuer obtained the written consent of the expert to the use of the report, statement or<br />

opinion, if the consent had not been withdrawn in writing before the document was released or the public oral statement was<br />

made, if the person or company proves that,<br />

(a) the person or company did not know and had no reasonable grounds to believe that there had been a<br />

misrepresentation in the part of the document or public oral statement made on the authority of the expert; and<br />

(b) the part of the document or oral public statement fairly represented the report, statement or opinion made by<br />

the expert.<br />

Same<br />

(12) An expert is not liable in an action under section 138.3 with respect to any part of a document or public oral statement<br />

that includes, summarizes or quotes from a report, statement or opinion made by the expert, if the expert proves that the written<br />

consent previously provided was withdrawn in writing before the document was released or the public oral statement was made.<br />

Release of documents<br />

(13) A person or company is not liable in an action under section 138.3 in respect of a misrepresentation in a document,<br />

other than a document required to be filed with the Commission, if the person or company proves that, at the time of release<br />

of the document, the person or company did not know and had no reasonable grounds to believe that the document would<br />

be released.<br />

Derivative information<br />

(14) A person or company is not liable in an action under section 138.3 for a misrepresentation in a document or a public<br />

oral statement, if the person or company proves that,<br />

(a) the misrepresentation was also contained in a document filed by or on behalf of another person or company, other<br />

than the responsible issuer, with the Commission or any other securities regulatory authority in Canada or a stock<br />

exchange and was not corrected in another document filed by or on behalf of that other person or company with the<br />

Commission or that other securities regulatory authority in Canada or stock exchange before the release of the<br />

document or the public oral statement made by or on behalf of the responsible issuer;<br />

(b) the document or public oral statement contained a reference identifying the document that was the source of the<br />

misrepresentation; and<br />

(c) when the document was released or the public oral statement was made, the person or company did not know and<br />

had no reasonable grounds to believe that the document or public oral statement contained a misrepresentation.<br />

Where corrective action taken<br />

(15) A person or company, other than the responsible issuer, is not liable in an action under section 138.3 if the<br />

misrepresentation or failure to make timely disclosure was made without the knowledge or consent of the person or company<br />

and, if, after the person or company became aware of the misrepresentation before it was corrected, or the failure to make<br />

timely disclosure before it was disclosed in the manner required under this Act,<br />

(a) the person or company promptly notified the board of directors of the responsible issuer or other persons acting<br />

in a similar capacity of the misrepresentation or the failure to make timely disclosure; and<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

47


A<br />

(b) if no correction of the misrepresentation or no subsequent disclosure of the material change in the manner required<br />

under this Act was made by the responsible issuer within two business days after the notification under clause (a), the<br />

person or company, unless prohibited by law or by professional confidentiality rules, promptly and in writing notified<br />

the Commission of the misrepresentation or failure to make timely disclosure.<br />

DAMAGES<br />

Assessment of damages<br />

138.5 (1) Damages shall be assessed in favour of a person or company that acquired an issuer’s securities after the release of<br />

a document or the making of a public oral statement containing a misrepresentation or after a failure to make timely disclosure<br />

as follows:<br />

1. In respect of any of the securities of the responsible issuer that the person or company subsequently disposed of on or<br />

before the 10th trading day after the public correction of the misrepresentation or the disclosure of the material change in<br />

the manner required under this Act, assessed damages shall equal the difference between the average price paid for those<br />

securities (including any commissions paid in respect thereof) and the price received upon the disposition of those securities<br />

(without deducting any commissions paid in respect of the disposition), calculated taking into account the result of hedging<br />

or other risk limitation transactions.<br />

2. In respect of any of the securities of the responsible issuer that the person or company subsequently disposed of after<br />

the 10th trading day after the public correction of the misrepresentation or the disclosure of the material change in the<br />

manner required under this Act, assessed damages shall equal the lesser of,<br />

i. an amount equal to the difference between the average price paid for those securities (including any commissions<br />

paid in respect thereof) and the price received upon the disposition of those securities (without deducting any<br />

commissions paid in respect of the disposition), calculated taking into account the result of hedging or other risk<br />

limitation transactions, and<br />

ii. an amount equal to the number of securities that the person disposed of, multiplied by the difference between the<br />

average price per security paid for those securities (including any commissions paid in respect thereof determined on a<br />

per security basis) and,<br />

A. if the issuer’s securities trade on a published market, the trading price of the issuer’s securities on the principal<br />

market (as those terms are defined in the regulations) for the 10 trading days following the public correction of the<br />

misrepresentation or the disclosure of the material change in the manner required under this Act, or<br />

B. if there is no published market, the amount that the court considers just.<br />

3. In respect of any of the securities of the responsible issuer that the person or company has not disposed of, assessed<br />

damages shall equal the number of securities acquired, multiplied by the difference between the average price per security<br />

paid for those securities (including any commissions paid in respect thereof determined on a per security basis) and,<br />

i. if the issuer’s securities trade on a published market, the trading price of the issuer’s securities on the principal<br />

market (as such terms are defined in the regulations) for the 10 trading days following the public correction of the<br />

misrepresentation or the disclosure of the material change in the manner required under this Act, or ii. if there is no<br />

published market, the amount that the court considers just.<br />

Same<br />

(2) Damages shall be assessed in favour of a person or company that disposed of securities after a document was released<br />

or a public oral statement made containing a misrepresentation or after a failure to make timely disclosure as follows:<br />

1. In respect of any of the securities of the responsible issuer that the person or company subsequently acquired<br />

on or before the 10th trading day after the public correction of the misrepresentation or the disclosure of the material<br />

change in the manner required under this Act, assessed damages shall equal the difference between the average price<br />

received upon the disposition of those securities (deducting any commissions paid in respect of the disposition) and<br />

the price paid for those securities (without including any commissions paid in respect thereof), calculated taking<br />

into account the result of hedging or other risk limitation transactions.<br />

2. In respect of any of the securities of the responsible issuer that the person or company subsequently acquired<br />

after the 10th trading day after the public correction of the misrepresentation or the disclosure of the material change<br />

in the manner required under this Act, assessed damages shall equal the lesser of,<br />

i. an amount equal to the difference between the average price received upon the disposition of those securities<br />

(deducting any commissions paid in respect of the disposition) and the price paid for those securities (without<br />

48 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


A<br />

including any commissions paid in respect thereof), calculated taking into account the result of hedging or other<br />

risk limitation transactions, and<br />

ii. an amount equal to the number of securities that the person disposed of, multiplied by the difference between<br />

the average price per security received upon the disposition of those securities (deducting any commissions paid<br />

in respect of the disposition determined on a per security basis) and,<br />

A. if the issuer’s securities trade on a published market, the trading price of the issuer’s securities on the<br />

principal market (as those terms are defined in the regulations) for the 10 trading days following the public<br />

correction of the misrepresentation or the disclosure of the material change in the manner required under this<br />

Act, or<br />

B. if there is no published market, the amount that the court considers just.<br />

3. In respect of any of the securities of the responsible issuer that the person or company has not acquired, assessed<br />

damages shall equal the number of securities that the person or company disposed of, multiplied by the difference<br />

between the average price per security received upon the disposition of those securities (deducting any commissions<br />

paid in respect of the disposition determined on a per security basis) and,<br />

i. if the issuer’s securities trade on a published market, the trading price of the issuer’s securities on the principal<br />

market (as such terms are defined in the regulations) for the 10 trading days following the public correction of the<br />

misrepresentation or the disclosure of the material change in the manner required under this Act, or<br />

ii. if there is no published market, then the amount that the court considers just.<br />

Same<br />

(3) Despite subsections (1) and (2), assessed damages shall not include any amount that the defendant proves is<br />

attributable to a change in the market price of securities that is unrelated to the misrepresentation or the failure to make<br />

timely disclosure.<br />

Proportionate liability<br />

138.6 (1) In an action under section 138.3, the court shall determine, in respect of each defendant found liable in the<br />

action, the defendant’s responsibility for the damages assessed in favour of all plaintiffs in the action, and each such<br />

defendant shall be liable, subject to the limits set out in subsection 138.7 (1), to the plaintiffs for only that portion of<br />

the aggregate amount of damages assessed in favour of the plaintiffs that corresponds to that defendant’s responsibility<br />

for the damages.<br />

Same<br />

(2) Despite subsection (1), where, in an action under section 138.3 in respect of a misrepresentation or a failure to make<br />

timely disclosure, a court determines that a particular defendant, other than the responsible issuer, authorized, permitted<br />

or acquiesced in the making of the misrepresentation or the failure to make timely disclosure while knowing it to be a<br />

misrepresentation or a failure to make timely disclosure, the whole amount of the damages assessed in the action may be<br />

recovered from that defendant.<br />

Same<br />

(3) Each defendant in respect of whom the court has made a determination under subsection (2) is jointly and severally<br />

liable with each other defendant in respect of whom the court has made a determination under subsection (2).<br />

Same<br />

(4) Any defendant against whom recovery is obtained under subsection (2) is entitled to claim contribution from any other<br />

defendant who is found liable in the action.<br />

Limits on damages<br />

138.7 (1) Despite section 138.5, the damages payable by a person or company in an action under section 138.3 is the lesser of,<br />

(a) the aggregate damages assessed against the person or company in the action; and<br />

(b) the liability limit for the person or company less the aggregate of all damages assessed after appeals, if any,<br />

against the person or company in all other actions brought under section 138.3, and under comparable legislation<br />

in other provinces or territories in Canada in respect of that misrepresentation or failure to make timely disclosure,<br />

and less any amount paid in settlement of any such actions.<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

49


A<br />

Same<br />

(2) Subsection (1) does not apply to a person or company, other than the responsible issuer, if the plaintiff proves that the person<br />

or company authorized, permitted or acquiesced in the making of the misrepresentation or the failure to make timely disclosure while<br />

knowing that it was a misrepresentation or a failure to make timely disclosure, or influenced the making of the misrepresentation or<br />

the failure to make timely disclosure while knowing that it was a misrepresentation or a failure to make timely disclosure.<br />

PROCEDURAL MATTERS<br />

Leave to proceed<br />

138.8 (1) No action may be commenced under section 138.3 without leave of the court granted upon motion with notice<br />

to each defendant. The court shall grant leave only where it is satisfied that,<br />

(a) the action is being brought in good faith; and<br />

(b) there is a reasonable possibility that the action will be resolved at trial in favour of the plaintiff.<br />

Same<br />

(2) Upon an application under this section, the plaintiff and each defendant shall serve and file one or more affidavits<br />

setting forth the material facts upon which each intends to rely.<br />

Same<br />

(3) The maker of such an affidavit may be examined on it in accordance with the rules of court.<br />

Same<br />

(4) A copy of the application for leave to proceed and any affidavits filed with the court shall be sent to the Commission<br />

when filed.<br />

Notice<br />

138.9 A person or company that has been granted leave to commence an action under section 138.3 shall,<br />

(a) promptly issue a news release disclosing that leave has been granted to commence an action under section 138.3;<br />

(b) send a written notice to the Commission within seven days, together with a copy of the news release; and<br />

(c) send a copy of the statement of claim or other originating document to the Commission when filed.<br />

Restriction on discontinuation, etc., of action<br />

138.10 An action under section 138.3 shall not be discontinued, abandoned or settled without the approval of the court given<br />

on such terms as the court thinks fit including, without limitation, terms as to costs, and in determining whether to approve<br />

the settlement of the action, the court shall consider, among other things, whether there are any other actions outstanding<br />

under section 138.3 or under comparable legislation in other provinces or territories in Canada in respect of the same<br />

misrepresentation or failure to make timely disclosure.<br />

Costs<br />

138.11 Despite the Courts of Justice Act and the Class Proceedings Act, 1992, the prevailing party in an action under section<br />

138.3 is entitled to costs determined by a court in accordance with applicable rules of civil procedure.<br />

Power of the Commission<br />

138.12 The Commission may intervene in an action under section 138.3 and in an application for leave under section 138.8.<br />

No derogation from other rights<br />

138.13 The right of action for damages and the defences to an action under section 138.3 are in addition to, and without<br />

derogation from, any other rights or defences the plaintiff or defendant may have in an action brought otherwise than under<br />

this Part.<br />

50 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


A<br />

Limitation period<br />

138.14 No action shall be commenced under section 138.3,<br />

(a) in the case of misrepresentation in a document, later than the earlier of,<br />

(i) three years after the date on which the document containing the misrepresentation was first released, and<br />

(ii) six months after the issuance of a news release disclosing that leave has been granted to commence an action<br />

under section 138.3 or under comparable legislation in the other provinces or territories in Canada in respect of<br />

the same misrepresentation;<br />

(b) in the case of a misrepresentation in a public oral statement, later than the earlier of,<br />

(i) three years after the date on which the public oral statement containing the misrepresentation was made, and<br />

(ii) six months after the issuance of a news release disclosing that leave has been granted to commence an action<br />

under section 138.3 or under comparable legislation in another province or territory of Canada in respect of the<br />

same misrepresentation; and<br />

(c) in the case of a failure to make timely disclosure, later than the earlier of,<br />

(i) three years after the date on which the requisite disclosure was required to be made, and<br />

(ii) six months after the issuance of a news release disclosing that leave has been granted to commence an action<br />

under section 138.3 or under comparable legislation in another province or territory of Canada in respect of the<br />

same failure to make timely disclosure.<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

51


Summary of Liabilities<br />

B<br />

APPENDIX


B-1 SUMMARY OF LIABILITIES<br />

CLAIMS AGAINST:<br />

TYPE OF CLAIM:<br />

MISREPRESENTATION<br />

– Core Document<br />

– Released by Issuer<br />

Responsible Issuer<br />

Plaintiff proves it acquired or disposed of securities between release and correction<br />

of misrepresentation<br />

Defences: Issuer made a Reasonable Investigation, Plaintiff knew of misrepresentation,<br />

Forward-Looking Information, Reliance on Experts, Derivative Information<br />

Director of<br />

Responsible Issuer<br />

Plaintiff proves it acquired or disposed of securities between release and correction<br />

of misrepresentation<br />

Defences: Director made a Reasonable Investigation, Plaintiff knew of misrepresentation,<br />

Forward-Looking Information, Reliance on Experts, Corrective Action, Derivative Information<br />

Officer of<br />

Responsible Issuer<br />

Plaintiff proves it acquired or disposed of securities between release and correction<br />

of misrepresentation, and that the officer authorized, permitted or acquiesced in<br />

the release<br />

Defences: Officer made a Reasonable Investigation, Plaintiff knew of misrepresentation,<br />

Forward-Looking Information, Reliance on Experts, Corrective Action,<br />

Derivative Information<br />

Influential Person<br />

Plaintiff proves it acquired or disposed of securities between release and correction<br />

of misrepresentation, and that the influential person knowingly influenced issuer to release<br />

or director or officer of issuer to authorize, permit or acquiesce in the release<br />

Defences: Influential Person made a Reasonable Investigation, Plaintiff knew of<br />

misrepresentation, Forward-Looking Information, Reliance on Experts, Corrective Action,<br />

Derivative Information<br />

Director or Officer of<br />

Influential Person<br />

Plaintiff proves it acquired or disposed of securities between release and correction<br />

of misrepresentation, and that the director or officer of influential person knowingly<br />

influenced issuer to release or director or officer of issuer to authorize, permit or<br />

acquiesce in the release<br />

Defences: Director or Officer made a Reasonable Investigation, Plaintiff knew of<br />

misrepresentation, Forward-Looking Information, Reliance on Experts,<br />

Corrective Action, Derivative Information<br />

Expert<br />

Plaintiff proves it acquired or disposed of securities between release and correction<br />

of misrepresentation, misrepresentation is also in a report made by expert, document<br />

incorporates report, expert consented in writing to its use<br />

Defences: Expert made a Reasonable Investigation, Plaintiff knew of misrepresentation,<br />

Forward-Looking Information, Corrective Action, Derivative Information,<br />

Withdrawal of Consent<br />

Spokesperson<br />

Not relevant<br />

54 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


SUMMARY OF LIABILITIES<br />

B-2<br />

TYPE OF CLAIM:<br />

CLAIMS AGAINST: MISREPRESENTATION – Non-Core Document<br />

– Released by Issuer<br />

Responsible Issuer<br />

Plaintiff proves it acquired or disposed of securities between release and correction<br />

of misrepresentation, and that issuer either knew of misrepresentation at time of release or<br />

deliberately avoided acquiring knowledge or was guilty of gross misconduct<br />

Defences: Plaintiff knew of misrepresentation, Reasonable Investigation,<br />

Forward-Looking Information, Reliance on Experts, Release without issuer’s<br />

knowledge, Derivative Information<br />

Director of<br />

Responsible Issuer<br />

Plaintiff proves it acquired or disposed of securities between release and correction<br />

of misrepresentation, and that the director either knew of misrepresentation at time of<br />

release or deliberately avoided acquiring knowledge or was guilty of gross misconduct<br />

Defences: Plaintiff knew of misrepresentation, Director made a Reasonable Investigation,<br />

Forward-Looking Information, Corrective Action, Reliance on Experts, Release without<br />

director’s knowledge, Derivative Information<br />

Officer of<br />

Responsible Issuer<br />

Plaintiff proves it acquired or disposed of securities between release and correction of<br />

misrepresentation, and that the officer authorized, permitted or acquiesced in the release,<br />

and that officer either knew of misrepresentation at time of release or deliberately avoided<br />

acquiring knowledge or was guilty of gross misconduct<br />

Defences: Plaintiff knew of misrepresentation, Officer made a Reasonable Investigation,<br />

Forward-Looking Information, Reliance on Experts, Release without officer’s knowledge,<br />

Corrective Action, Derivative Information<br />

Influential Person<br />

Plaintiff proves it acquired or disposed of securities between release and correction of<br />

misrepresentation, and that the director or officer knowingly influenced issuer to release or<br />

director or officer of issuer to authorize, permit or acquiesce in the release and that director<br />

or officer either knew of misrepresentation at time of release or deliberately avoided<br />

acquiring knowledge or was guilty of gross misconduct<br />

Defences: Plaintiff knew of misrepresentation, Influential Person made a Reasonable<br />

Investigation, Forward-Looking Information, Reliance on Experts, Release without<br />

Influential Person’s knowledge, Corrective Action, Derivative Information<br />

Director or Officer of<br />

Influential Person<br />

Plaintiff proves it acquired or disposed of securities between release and correction of<br />

misrepresentation, and that the director or officer knowingly influenced issuer to release or<br />

director or officer of issuer to authorize, permit or acquiesce in the release, and that director<br />

or officer of influential person either knew of misrepresentation at time of release or<br />

deliberately avoided acquiring knowledge or was guilty of gross misconduct<br />

Defences: Plaintiff knew of misrepresentation, Director or Officer made a Reasonable<br />

Investigation, Forward-Looking Information, Reliance on Experts, Release without director’s<br />

or officer’s knowledge, Corrective Action, Derivative Information<br />

Expert<br />

Plaintiff proves it acquired or disposed of securities between release and correction of<br />

misrepresentation, misrepresentation is also in a report, made by expert, document<br />

incorporates report, expert consented in writing to its use<br />

Defences: Expert made a Reasonable Investigation, Plaintiff knew of misrepresentation,<br />

Forward-Looking Information, Release without expert’s knowledge, Corrective Action,<br />

Derivative Information, Withdrawal of Consent<br />

Spokesperson<br />

Not relevant<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

55


B-3 SUMMARY OF LIABILITIES<br />

TYPE OF CLAIM:<br />

CLAIMS AGAINST: MISREPRESENTATION – Non-core Document<br />

– Released by Influential Person<br />

Responsible Issuer<br />

Plaintiff proves it acquired or disposed of securities between release and correction of<br />

misrepresentation, and that a director or officer of issuer authorized, permitted or<br />

acquiesced in the release (or where issuer is investment fund, manager authorized, permitted or<br />

acquiesced in release)<br />

Plaintiff proves issuer either knew of misrepresentation at time of release or deliberately<br />

avoided acquiring knowledge or was guilty of gross misconduct<br />

Defences: Plaintiff knew of misrepresentation, Reasonable Investigation,<br />

Forward-Looking Information, Reliance on Experts, Release without issuer’s knowledge,<br />

Derivative Information<br />

Director of<br />

Responsible Issuer<br />

Plaintiff proves it acquired or disposed of securities between release and correction of<br />

misrepresentation, and that the director authorized, permitted or acquiesced in the release<br />

Plaintiff proves director either knew of misrepresentation at time of release or deliberately<br />

avoided acquiring knowledge or was guilty of gross misconduct<br />

Defences: Plaintiff knew of misrepresentation, Director made a Reasonable Investigation,<br />

Forward-Looking Information, Reliance on Experts, Release without director’s knowledge,<br />

Corrective Action, Derivative Information<br />

Officer of<br />

Responsible Issuer<br />

Plaintiff proves it acquired or disposed of securities between release and correction of<br />

misrepresentation, and that the officer authorized, permitted or acquiesced in the release<br />

Plaintiff proves officer either knew of misrepresentation at time of release or deliberately<br />

avoided acquiring knowledge or was guilty of gross misconduct<br />

Defences: Plaintiff knew of misrepresentation, Officer made a Reasonable Investigation,<br />

Forward-Looking Information, Reliance on Experts, Release without officer’s knowledge,<br />

Corrective Action, Derivative Information<br />

Influential Person<br />

Plaintiff proves it acquired or disposed of securities between release and correction of<br />

misrepresentation<br />

Plaintiff proves influential person either knew of misrepresentation at time of release or<br />

deliberately avoided acquiring knowledge or was guilty of gross misconduct<br />

Defences: Plaintiff knew of misrepresentation, Influential Person made a Reasonable<br />

Investigation, Forward-Looking Information, Reliance on Experts, Release without Influential<br />

Person’s knowledge, Corrective Action, Derivative Information<br />

56 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


SUMMARY OF LIABILITIES<br />

B-3<br />

Director or Officer of<br />

Influential Person<br />

TYPE OF CLAIM:<br />

CLAIMS AGAINST: MISREPRESENTATION – Non-core Document<br />

– Released by Influential Person<br />

Plaintiff proves it acquired or disposed of securities between release and correction<br />

of misrepresentation<br />

Plaintiff proves director or officer either knew of misrepresentation at time of release or<br />

deliberately avoided acquiring knowledge or was guilty of gross misconduct<br />

Defences: Plaintiff knew of misrepresentation, Director or Officer made a Reasonable<br />

Investigation, Forward-Looking Information, Reliance on Experts, Release without director’s<br />

or officer’s knowledge, Corrective Action, Derivative Information<br />

Expert<br />

Plaintiff proves it acquired or disposed of securities between release and correction of<br />

misrepresentation, misrepresentation is also in a report, statement or opinion made by expert,<br />

document incorporates report, statement or opinion, expert consented in writing to its use<br />

Defences: Expert made a Reasonable Investigation, Plaintiff knew of misrepresentation,<br />

Forward-Looking Information, Release without expert’s knowledge, Corrective Action,<br />

Derivative Information, Withdrawal of Consent<br />

Spokesperson<br />

Not relevant<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

57


B-4<br />

SUMMARY OF LIABILITIES<br />

TYPE OF CLAIM:<br />

CLAIMS AGAINST: MISREPRESENTATION – Public Oral Statement<br />

by Issuer<br />

Responsible Issuer<br />

Plaintiff proves it acquired or disposed of securities between release and correction of<br />

misrepresentation in statement, the statement relates to business or affairs of issuer, and is<br />

made by a person with actual, implied or apparent authority to speak for issuer<br />

Plaintiff proves issuer either knew of misrepresentation at time of statement or deliberately<br />

avoided acquiring knowledge or was guilty of gross misconduct<br />

Defences: Plaintiff knew of misrepresentation, Reasonable Investigation, Forward-Looking<br />

Information,<br />

Reliance on Experts, Release without issuer’s knowledge, Derivative Information<br />

Director of<br />

Responsible Issuer<br />

Plaintiff proves it acquired or disposed of securities between release and correction of<br />

misrepresentation in statement, the statement relates to business or affairs of issuer, and is<br />

made by a person with actual, implied or apparent authority to speak for issuer<br />

Director authorized, permitted or acquiesced in making the statement<br />

Plaintiff proves director either knew of misrepresentation at time of statement or deliberately<br />

avoided acquiring knowledge or was guilty of gross misconduct<br />

Defences: Plaintiff knew of misrepresentation, Director made a Reasonable Investigation,<br />

Forward-Looking Information, Reliance on Experts, Release without director’s knowledge,<br />

Derivative Information<br />

Officer of<br />

Responsible Issuer<br />

Plaintiff proves it acquired or disposed of securities between release and correction of<br />

misrepresentation in statement, the statement relates to business or affairs of issuer, and is<br />

made by a person with actual, implied or apparent authority to speak for issuer<br />

Officer authorized, permitted or acquiesced in making the statement<br />

Plaintiff proves officer either knew of misrepresentation at time of statement or deliberately<br />

avoided acquiring knowledge or was guilty of gross misconduct<br />

Defences: Plaintiff knew of misrepresentation, Officer made a Reasonable Investigation,<br />

Forward-Looking Information, Reliance on Experts, Release without officer’s knowledge,<br />

Derivative Information<br />

Influential Person<br />

Plaintiff proves it acquired or disposed of securities between release and correction of<br />

misrepresentation in statement, the statement relates to business or affairs of issuer, and is<br />

made by a person with actual, implied or apparent authority to speak for issuer<br />

Influential Person knowingly influenced the person who made the statement to make it or a<br />

director or officer of the issuer to authorize, permit or acquiesce in making the statement<br />

Plaintiff proves Influential Person either knew of misrepresentation at time of statement or<br />

deliberately avoided acquiring knowledge or was guilty of gross misconduct<br />

Defences: Plaintiff knew of misrepresentation, Influential Person made a Reasonable Investigation,<br />

Forward-Looking Information, Reliance on Experts, Release without Influential Person’s knowledge,<br />

Derivative Information<br />

58 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


SUMMARY OF LIABILITIES<br />

B-4<br />

TYPE OF CLAIM:<br />

CLAIMS AGAINST: MISREPRESENTATION – Public Oral Statement<br />

by Issuer<br />

Director or Officer of<br />

Influential Person<br />

Plaintiff proves it acquired or disposed of securities between release and correction of<br />

misrepresentation in statement, the statement relates to business or affairs of issuer, and is<br />

made by a person with actual, implied or apparent authority to speak for issuer<br />

Director or officer of Influential Person knowingly influenced the person who made the<br />

statement to make it or the director or officer of the issuer to authorize, permit or acquiesce in<br />

making the statement<br />

Plaintiff proves director or officer of Influential Person either knew of misrepresentation at time<br />

of statement or deliberately avoided acquiring knowledge or was guilty of gross misconduct<br />

Defences: Director or Officer made a Reasonable Investigation, Plaintiff knew of<br />

misrepresentation, Forward-Looking Information, Reliance on Experts, Release without<br />

director’s or officer’s knowledge, Derivative Information<br />

Expert<br />

Plaintiff proves it acquired or disposed of securities between release and correction of<br />

misrepresentation in statement, the statement relates to business or affairs of issuer,<br />

and is made by a person with actual, implied or apparent authority to speak for issuer,<br />

misrepresentation is also in a report, made by expert, statement incorporates report,<br />

expert consented in writing to its use<br />

Defences: Expert made a Reasonable Investigation, Plaintiff knew of misrepresentation,<br />

Forward-Looking Information, Release without expert’s knowledge, Corrective Action,<br />

Derivative Information, Withdrawal of Consent<br />

Spokesperson<br />

Plaintiff proves it acquired or disposed of securities between release and correction of<br />

misrepresentation in statement, and that the statement relates to business or affairs<br />

of issuer<br />

Plaintiff proves person either knew of misrepresentation at time of statement or<br />

deliberately avoided acquiring knowledge or was guilty of gross misconduct<br />

Defences: Plaintiff knew of misrepresentation, Forward-Looking Information,<br />

Other Person made a Reasonable Investigation, Reliance on Experts, Release without<br />

person’s knowledge, Corrective Action, Derivative Information<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

59


B-5 SUMMARY OF LIABILITIES<br />

TYPE OF CLAIM:<br />

CLAIMS AGAINST: MISREPRESENTATION – Public Oral Statement by<br />

Influential Person<br />

Responsible Issuer<br />

Plaintiff proves it acquired or disposed of securities between release and correction<br />

of misrepresentation in statement, and that the statement relates to business or affairs<br />

of issuer<br />

Plaintiff proves issuer either knew of misrepresentation at time of statement or deliberately<br />

avoided acquiring knowledge or was guilty of gross misconduct<br />

Defences: Plaintiff knew of misrepresentation, Reasonable Investigation,<br />

Forward-Looking Information, Reliance on Experts, Release without issuer’s knowledge,<br />

Derivative Information<br />

Director of<br />

Responsible Issuer<br />

Plaintiff proves it acquired or disposed of securities between release and correction<br />

of misrepresentation in statement, and that the statement relates to business or affairs<br />

of issuer<br />

Director authorized, permitted or acquiesced in making the statement<br />

Plaintiff proves director either knew of misrepresentation at time of statement or<br />

deliberately avoided acquiring knowledge or was guilty of gross misconduct<br />

Defences: Plaintiff knew of misrepresentation, Director made a Reasonable Investigation,<br />

Forward-Looking Information, Reliance on Experts, Release without director’s knowledge,<br />

Corrective Action, Derivative Information<br />

Officer of<br />

Responsible Issuer<br />

Plaintiff proves it acquired or disposed of securities between release and correction<br />

of misrepresentation in statement, and that the statement relates to business or affairs<br />

of issuer<br />

Plaintiff proves director or officer either knew of misrepresentation at time of statement or<br />

deliberately avoided acquiring knowledge or was guilty of gross misconduct<br />

Defences: Plaintiff knew of misrepresentation, Influential Person made a Reasonable<br />

Investigation, Forward-Looking Information, Reliance on Experts, Release without Influential<br />

Person’s knowledge, Corrective Action, Derivative Information<br />

Influential Person<br />

Plaintiff proves it acquired or disposed of securities between release and correction<br />

of misrepresentation<br />

Plaintiff proves influential person either knew of misrepresentation at time of release or<br />

deliberately avoided acquiring knowledge or was guilty of gross misconduct<br />

Defences: Plaintiff knew of misrepresentation, Influential Person made a Reasonable<br />

Investigation, Forward-Looking Information, Reliance on Experts, Release without Influential<br />

Person’s knowledge, Corrective Action, Derivative Information<br />

60 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


SUMMARY OF LIABILITIES<br />

B-5<br />

Director or Officer of<br />

Influential Person<br />

TYPE OF CLAIM:<br />

CLAIMS AGAINST: MISREPRESENTATION – Public Oral Statement by<br />

Influential Person<br />

Plaintiff proves it acquired or disposed of securities between release and correction of<br />

misrepresentation in statement, and that the statement relates to business or affairs of issuer<br />

Director or officer authorized, permitted or acquiesced in making the statement<br />

Plaintiff proves director or officer either knew of misrepresentation at time of statement or<br />

deliberately avoided acquiring knowledge or was guilty of gross misconduct<br />

Defences: Plaintiff knew of misrepresentation, Director or Officer made a Reasonable<br />

Investigation, Forward-Looking Information, Reliance on Experts, Release without director’s<br />

or officer’s knowledge, Corrective Action, Derivative Information<br />

Expert<br />

Plaintiff proves it acquired or disposed of securities between release of statement and<br />

correction of misrepresentation, misrepresentation is also in a report, made by expert,<br />

statement incorporates report, expert consented in writing to its use<br />

Defences: Expert made a Reasonable Investigation, Plaintiff knew of misrepresentation,<br />

Forward-Looking Information, Release without expert’s knowledge, Corrective Action,<br />

Derivative Information, Withdrawal of Consent<br />

Spokesperson<br />

Plaintiff proves it acquired or disposed of securities between release and correction<br />

of misrepresentation in statement, and that the statement relates to business or affairs<br />

of issuer<br />

Plaintiff proves person either knew of misrepresentation at time of statement or<br />

deliberately avoided acquiring knowledge or was guilty of gross misconduct<br />

Defences: Plaintiff knew of misrepresentation, Other Person made a Reasonable<br />

Investigation, Forward-Looking Information, Reliance on Experts, Release without person’s<br />

knowledge, Corrective Action, Derivative Information<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

61


B-6<br />

SUMMARY OF LIABILITIES<br />

TYPE OF CLAIM:<br />

CLAIMS AGAINST: MISREPRESENTATION – Issuer’s Failure to Make Timely<br />

Disclosure of a Material Change<br />

Responsible Issuer<br />

Plaintiff proves it acquired or disposed of securities between time when material change<br />

had to be disclosed and later disclosure<br />

Defences: Issuer made a Reasonable Investigation, Plaintiff knew of failure to make timely<br />

disclosure, Reliance on Experts, Confidential Disclosure of material change had been<br />

made to OSC<br />

Director of<br />

Responsible Issuer<br />

Plaintiff proves it acquired or disposed of securities between time when material change<br />

had to be disclosed and later disclosure, and that the director authorized that, permitted or<br />

acquiesced in the failure<br />

Plaintiff proves director knew of change at time failure to disclosure occurred and that it was<br />

material, or the director deliberately avoided acquiring knowledge, or the director was<br />

guilty of gross misconduct<br />

Defences: Director made a Reasonable Investigation, Plaintiff knew of failure to make timely<br />

disclosure, Reliance on Experts, Corrective Action, Confidential Disclosure of material<br />

change had been made to OSC<br />

Officer of<br />

Responsible Issuer<br />

Plaintiff proves it acquired or disposed of securities between time when material<br />

change had to be disclosed and later disclosure, and that the officer authorized,<br />

permitted or acquiesced in the failure<br />

Defences: Officer made a Reasonable Investigation, Plaintiff knew of failure to make<br />

timely disclosure, Reliance on Experts, Corrective Action, Confidential Disclosure of<br />

material change had been made to OSC<br />

Influential Person<br />

Plaintiff proves it acquired or disposed of securities between time when material change<br />

had to be disclosed and later disclosure, and that the Influential Person knowingly<br />

influenced the issuer to fail to make timely disclosure or a director of officer of the issuer<br />

to authorize, permit or acquiesce in the failure to make timely disclosure<br />

Where Influential Person is not a fund manager, the plaintiff proves the Influential Person<br />

knew of change at time failure to disclosure occurred and that it was material, or the<br />

director or officer deliberately avoided acquiring knowledge, or was guilty of gross<br />

misconduct<br />

Defences: Reasonable Investigation if a fund manager, Plaintiff knew of failure to make<br />

timely disclosure, Reliance on Experts, Corrective Action, Confidential Disclosure of<br />

material change had been made to OSC<br />

Director or Officer of<br />

Influential Person<br />

Plaintiff proves it acquired or disposed of securities between time when material change<br />

had to be disclosed and later disclosure, and that the director or officer knowingly<br />

influenced the issuer to fail to make timely disclosure or a director of officer of the issuer<br />

to authorize, permit or acquiesce in the failure to make timely disclosure<br />

Where director or officer is not a director or officer of a fund manager, the plaintiff proves<br />

director or officer either knew of change at time failure to disclosure occurred and that it<br />

was material, the director or officer deliberately avoided acquiring knowledge or was guilty<br />

of gross misconduct<br />

Defences: Reasonable Investigation if director or officer of a fund manager,<br />

Plaintiff knew of failure to make timely disclosure, Reliance on Experts, Corrective Action,<br />

Derivative Information, Confidential Disclosure of material change had been made to OSC<br />

Expert<br />

Not relevant<br />

Spokesperson<br />

Not relevant<br />

62 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


Summary of Defences<br />

C<br />

APPENDIX


C<br />

SUMMARY OF DEFENCES<br />

NAME OF DEFENCE: DESCRIPTION: AVAILABLE FOR: AVAILABLE TO:<br />

Reasonable Investigation<br />

– Misrepresentation<br />

138.4(6)(a) and (7)<br />

Defendant proves that<br />

• before the release of the<br />

document or the making<br />

of the public oral<br />

statement containing the<br />

misrepresentation, the<br />

defendant conducted or<br />

caused to be conducted a<br />

reasonable investigation,<br />

and<br />

• at the time of the release<br />

of the document or the<br />

making of the public oral<br />

statement, the defendant<br />

had no reasonable<br />

grounds to believe that<br />

the document or public<br />

oral statement contained<br />

the misrepresentation<br />

Misrepresentation in core<br />

or non-core document<br />

released by or on behalf<br />

of issuer or influential<br />

person<br />

Misrepresentation in a<br />

public oral statement by<br />

or on behalf of issuer or<br />

influential person<br />

Issuer<br />

Directors of issuer<br />

Officers of issuer<br />

Influential persons<br />

Directors and officers<br />

of influential persons<br />

Experts<br />

Spokespersons<br />

Court to consider other<br />

factors in 138.4(7)<br />

Reasonable Investigation<br />

– Timely Disclosure<br />

138.4(6)(b) and (7)<br />

Defendant proves that<br />

• before the failure to<br />

make timely disclosure<br />

first occurred, the<br />

defendant conducted or<br />

caused to be conducted<br />

a reasonable<br />

investigation, and<br />

Failure to make timely<br />

disclosure of material<br />

change<br />

Issuer<br />

Directors of issuer<br />

Officers of issuer<br />

Influential persons<br />

Directors and officers<br />

of influential persons<br />

• the defendant has no<br />

reasonable grounds to<br />

believe that the failure<br />

to make timely<br />

disclosure would occur<br />

Court to consider other<br />

factors in 138.4(7)<br />

Plaintiff’s Knowledge –<br />

Misrepresentation<br />

138.4(5)(a)<br />

Defendant proves that the<br />

plaintiff acquired or<br />

disposed of the issuer’s<br />

security with knowledge<br />

that the document or<br />

public oral statement<br />

contained a<br />

misrepresentation<br />

Misrepresentation in<br />

core or non-core<br />

document released by<br />

or on behalf of issuer<br />

or influential person<br />

Misrepresentation in a<br />

public oral statement<br />

by or on behalf of<br />

issuer or influential<br />

person<br />

Issuer<br />

Directors of issuer<br />

Officers of issuer<br />

Influential persons<br />

Directors and officers<br />

of influential persons<br />

Experts<br />

Spokespersons<br />

64 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


SUMMARY OF DEFENCES<br />

C<br />

NAME OF DEFENCE: DESCRIPTION : AVAILABLE FOR: AVAILABLE TO:<br />

Plaintiff’s Knowledge –<br />

Failure to Make Timely<br />

Disclosure of material<br />

change<br />

138.4(5)(b)<br />

Defendant proves that the<br />

plaintiff acquired or<br />

disposed of the issuer’s<br />

security with knowledge<br />

of the undisclosed<br />

material change<br />

Failure to make timely<br />

disclosure of material<br />

change<br />

Issuer<br />

Directors of issuer<br />

Officers of issuer<br />

Influential persons<br />

Directors and officers<br />

of influential persons<br />

Forward-Looking<br />

Information –<br />

Documents<br />

138.4(9) and (10)<br />

If the misrepresentation<br />

is in forward-looking<br />

information<br />

in a document, defendant<br />

proves that<br />

• the document<br />

containing the forwardlooking<br />

information<br />

contained, proximate to<br />

the information,<br />

Misrepresentation in<br />

core or non-core<br />

document released by<br />

or on behalf of issuer<br />

or influential person<br />

Issuer<br />

Directors of issuer<br />

Officers of issuer<br />

Influential persons<br />

Directors and officers<br />

of influential persons<br />

Experts<br />

– reasonable cautionary<br />

language identifying<br />

the forward-looking<br />

information as such<br />

and identifying<br />

material factors that<br />

could cause actual<br />

results to differ<br />

materially from a<br />

conclusion, forecast<br />

or projection in the<br />

forward-looking<br />

information, and<br />

– a statement of the<br />

material factors or<br />

assumptions applied<br />

in drawing a<br />

conclusion or making<br />

a forecast or<br />

projection set out in<br />

the forward-looking<br />

information, and<br />

• the defendant had a<br />

reasonable basis for<br />

drawing the conclusions<br />

or making the forecasts<br />

or projections set out in<br />

the forward-looking<br />

information, and<br />

• the document in issue<br />

(i) is not released in<br />

connection with an<br />

initial public offering<br />

(including the<br />

prospectus of the<br />

responsible issuer filed<br />

in connection with a<br />

public distribution of<br />

securities) and (ii) is not<br />

a financial statement<br />

required to be filed<br />

under the Act.<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

65


C<br />

SUMMARY OF DEFENCES<br />

NAME OF DEFENCE: DESCRIPTION: AVAILABLE FOR: AVAILABLE TO:<br />

Forward-Looking<br />

Information –<br />

Public Oral Statements<br />

138.4(9)(9.1)(9.2)<br />

If the misrepresentation is<br />

in forward-looking<br />

information contained in a<br />

public oral statement, the<br />

defendant proves that<br />

• the person making the<br />

statement<br />

– made a cautionary<br />

statement that the<br />

oral statement<br />

contains forwardlooking<br />

information,<br />

– stated that (i) the<br />

actual results could<br />

differ materially from<br />

a conclusion,<br />

forecast or projection<br />

in the forwardlooking<br />

information,<br />

and (ii) certain<br />

material factors or<br />

assumptions were<br />

applied in drawing a<br />

conclusion or making<br />

a forecast for<br />

projection as<br />

reflected in the<br />

forward-looking<br />

information, and<br />

Misrepresentation in a<br />

public oral statement by<br />

or on behalf of issuer or<br />

influential person<br />

Issuer<br />

Directors of issuer<br />

Officers of issuer<br />

Influential persons<br />

Directors and officers<br />

of influential persons<br />

Experts<br />

Spokespersons<br />

– stated that additional<br />

information about (i)<br />

the material factors<br />

that could cause<br />

actual facts to differ<br />

materially from the<br />

conclusion, forecast<br />

or projection and (ii)<br />

the material factors<br />

or assumptions that<br />

were applied in<br />

drawing a conclusion<br />

or making a forecast<br />

or projection as<br />

reflected in the<br />

forward-looking<br />

information, is<br />

contained in a<br />

readily-available<br />

document or in a<br />

portion of such a<br />

document and has<br />

identified that<br />

document or the<br />

portion (138.4(9.1)),<br />

and<br />

• the defendant had a<br />

reasonable basis for<br />

drawing the conclusion<br />

or making the forecast<br />

or prediction<br />

(138.4(9) para. 2)<br />

66 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


SUMMARY OF DEFENCES<br />

C<br />

NAME OF DEFENCE: DESCRIPTION: AVAILABLE FOR: AVAILABLE TO:<br />

Reliance on Experts<br />

138.4(11)<br />

The part of the document<br />

or public oral statement<br />

containing the<br />

misrepresentation is part<br />

of a report, statement or<br />

opinion made by an<br />

expert that the<br />

responsible issuer<br />

obtained the written<br />

consent of the expert to<br />

use, so long as the<br />

consent has not been<br />

withdrawn in writing<br />

before the document was<br />

released or the public oral<br />

statement made and<br />

Misrepresentation in core<br />

or non-core document<br />

released by or on behalf<br />

of issuer or influential<br />

person<br />

Misrepresentation in a<br />

public oral statement by<br />

or on behalf of issuer or<br />

influential person<br />

Issuer<br />

Directors of issuer<br />

Officers of issuer<br />

Influential persons<br />

Directors and officers<br />

of influential persons<br />

Spokespersons<br />

• the defendant did<br />

not know and had no<br />

reasonable grounds<br />

to believe that there<br />

had been a<br />

misrepresentation in that<br />

part of the document or<br />

public oral statement,<br />

and<br />

• that part of the<br />

document or public oral<br />

statement fairly<br />

represented the report,<br />

statement or opinion of<br />

the expert<br />

Corrective Action –<br />

Misrepresentation<br />

138.4(15)<br />

The misrepresentation<br />

was made without the<br />

knowledge or consent of<br />

the defendant and if, after<br />

the defendant became<br />

aware of the<br />

misrepresentation before<br />

it was corrected,<br />

• the defendant promptly<br />

notified the issuer’s<br />

board of directors or<br />

other persons acting in<br />

a similar capacity of the<br />

misrepresentation, and<br />

Misrepresentation in<br />

core or non-core<br />

document released by<br />

or on behalf of issuer<br />

or influential person<br />

Misrepresentation in a<br />

public oral statement<br />

by or on behalf of<br />

issuer or influential<br />

person<br />

Directors of issuer<br />

Officers of issuer<br />

Influential persons<br />

Directors and officers<br />

of influential persons<br />

Experts<br />

Spokespersons<br />

• if no correction of the<br />

misrepresentation was<br />

made by the issuer<br />

within two business<br />

days after the<br />

defendant’s notification,<br />

the defendant promptly<br />

and in writing notified<br />

the Commission of the<br />

misrepresentation, so<br />

long as the disclosure<br />

was not prohibited by<br />

law or by professional<br />

confidentiality rules<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

67


C<br />

SUMMARY OF DEFENCES<br />

NAME OF DEFENCE: DESCRIPTION: AVAILABLE FOR: AVAILABLE TO:<br />

Corrective Action –<br />

Failure to Make Timely<br />

Disclosure<br />

138.4(15)<br />

The failure to make timely<br />

disclosure was made<br />

without the knowledge or<br />

consent of the defendant<br />

and if, after the defendant<br />

became aware of the<br />

failure to make timely<br />

disclosure before it was<br />

disclosed,<br />

Failure to make timely<br />

disclosure of material<br />

change<br />

Directors of issuer<br />

Officers of issuer<br />

Influential persons<br />

Directors and officers<br />

of influential persons<br />

• the defendant promptly<br />

notified the issuer’s<br />

board of directors or<br />

other persons acting in a<br />

similar capacity of the<br />

failure to make timely<br />

disclosure, and<br />

• if no subsequent<br />

disclosure of the<br />

material change as<br />

required by the Act was<br />

made by the issuer<br />

within two business<br />

days after the<br />

defendant’s notification,<br />

the defendant promptly<br />

and in writing notified<br />

the Commission of the<br />

failure to disclose, so<br />

long as the disclosure<br />

was not prohibited by<br />

law or by professional<br />

confidentiality rules<br />

68 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


SUMMARY OF DEFENCES<br />

C<br />

NAME OF DEFENCE: DESCRIPTION: AVAILABLE FOR: AVAILABLE TO:<br />

Confidential Disclosure of<br />

Material Change to OSC<br />

138.4(8)<br />

The defendant not liable if<br />

• the defendant proves<br />

that the material change<br />

was disclosed by the<br />

issuer in a report filed on<br />

a confidential basis with<br />

the Commission under<br />

subsection 75(3) of the<br />

Act<br />

Failure to make timely<br />

disclosure of material<br />

change<br />

Issuer<br />

Directors of issuer<br />

Officers of issuer<br />

Influential persons<br />

Directors and officers<br />

of influential persons<br />

• the issuer had a<br />

reasonable basis for<br />

making the disclosure on<br />

a confidential basis<br />

• where the information<br />

contained in the<br />

confidential report<br />

remains material,<br />

disclosure of the material<br />

change was made public<br />

promptly when the basis<br />

for confidentiality ceased<br />

to exist<br />

• the defendant or issuer<br />

did not release a<br />

document or make a<br />

public oral statement<br />

that, due to the<br />

undisclosed material<br />

change, contained a<br />

misrepresentation, and<br />

• where the material<br />

change became publicly<br />

known in a manner other<br />

than the manner<br />

required under the Act,<br />

the issuer promptly<br />

disclosed the material<br />

change in the manner<br />

required under the Act<br />

Withdrawal of Expert’s<br />

Consent<br />

138.4(12)<br />

Expert proves that the<br />

written consent<br />

previously provided for<br />

use of its report,<br />

statement or opinion was<br />

withdrawn in writing<br />

before the document was<br />

released or the public<br />

oral statement was made<br />

Misrepresentation in<br />

core or non-core<br />

document released by<br />

or on behalf of issuer<br />

or influential person<br />

Misrepresentation in a<br />

public oral statement<br />

by or on behalf of<br />

issuer or influential<br />

person<br />

Experts<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

69


C<br />

SUMMARY OF DEFENCES<br />

NAME OF DEFENCE: DESCRIPTION: AVAILABLE FOR: AVAILABLE TO:<br />

Derivative Information<br />

138.4(14)<br />

The defendant proves that<br />

• the misrepresentation<br />

was also contained in a<br />

document filed by or on<br />

behalf of another person<br />

or company, other than<br />

the issuer, with the<br />

Commission or any<br />

other securities<br />

regulatory authority in<br />

Canada or a stock<br />

exchange and was not<br />

corrected in another<br />

document filed by or on<br />

behalf of that other<br />

person or company<br />

before the release of the<br />

document or the making<br />

of the public oral<br />

statement,<br />

Misrepresentation in core<br />

or non-core document<br />

released by or on behalf<br />

of issuer or influential<br />

person<br />

Misrepresentation in a<br />

public oral statement by<br />

or on behalf of issuer or<br />

influential person<br />

Issuer<br />

Directors of issuer<br />

Officers of issuer<br />

Influential persons<br />

Directors and officers<br />

of influential persons<br />

Experts<br />

Spokespersons<br />

• the document or public<br />

oral statement contained<br />

a reference identifying<br />

the document that was<br />

the source of the<br />

misrepresentation, and<br />

• when the document was<br />

released or the public<br />

oral statement was<br />

made, the defendant did<br />

not know and had no<br />

reasonable grounds to<br />

believe that the<br />

document or public oral<br />

statement contained a<br />

misrepresentation<br />

Release Without<br />

Knowledge<br />

138.4(13)<br />

If the document in which<br />

the misrepresentation is<br />

made is not one that is<br />

required to be filed with<br />

the Commission, the<br />

defendant proves that at<br />

the time of release of the<br />

document, the defendant<br />

did not know and had no<br />

reasonable grounds to<br />

believe that the document<br />

would be released<br />

Misrepresentation in noncore<br />

document released<br />

by or on behalf of issuer<br />

or influential person<br />

Issuer<br />

Directors of issuer<br />

Officers of issuer<br />

Influential persons<br />

Directors and officers<br />

of influential persons<br />

Experts<br />

70 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


Calculating Damages<br />

D<br />

APPENDIX


D<br />

CALCULATING DAMAGES<br />

Formula for calculating damages<br />

(depends on when or if securities sold (under Situation 1)<br />

or repurchased (under Situation 2))<br />

Situation<br />

0-10 trading days after<br />

correction<br />

More than 10 trading<br />

days after correction<br />

Not sold/repurchased<br />

after correction<br />

(1)<br />

Securities purchased<br />

after a misrepresentation<br />

or failure to make timely<br />

disclosure of a material<br />

change and before the<br />

subsequent correction<br />

Damages equal:<br />

Purchase Price minus<br />

Actual Disposition Price<br />

Damages equal the<br />

lesser of:<br />

Purchase Price minus<br />

Actual Disposition Price<br />

-and-<br />

Purchase Price minus<br />

Benchmark Price<br />

Damages equal:<br />

Purchase Price minus<br />

Benchmark Price<br />

(2)<br />

Securities sold after a<br />

misrepresentation or<br />

failure to make timely<br />

disclosure of a material<br />

change and before the<br />

subsequent correction<br />

Damages equal:<br />

Actual Repurchase Price<br />

minus Sale Price<br />

Damages equal the<br />

lesser of:<br />

Actual Repurchase Price<br />

minus Sale Price<br />

-and-<br />

Benchmark Price minus<br />

Sale Price<br />

Damages equal:<br />

Benchmark Price minus<br />

Sale Price<br />

Concepts<br />

Situation (1)<br />

Purchase Price: Amount paid for the issuer’s securities purchased between the time of the<br />

misrepresentation or failure to disclose and the time of the correction. This is an average<br />

price and includes commissions.<br />

Actual Disposition Price: Amount received for the issuer’s securities sold after the<br />

correction. This is an average price and includes commissions.<br />

Situation (2)<br />

Sale Price: Amount received for the issuer’s securities sold between the time of the<br />

misrepresentation or failure to disclose and the time of the correction. This is an average<br />

price and excludes commissions.<br />

Actual Repurchase Price: Amount paid for the issuer’s securities repurchased after the<br />

correction. This is an average price and excludes commissions.<br />

Both situations<br />

Benchmark Price: The trading price of the issuer’s securities for the ten trading days<br />

following the correction. This will presumably be an average or weighted average price –<br />

the details are to be set out in the regulations. If there is no published market in the<br />

security, the Benchmark Price is to be fixed by the court at an amount it considers just.<br />

Damages awards are generally subject to the limits (absent knowledge, in some cases) set<br />

out in Appendix E.<br />

72 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


Limits on Damages<br />

E<br />

APPENDIX


E<br />

LIMITS ON DAMAGES<br />

CLAIMS AGAINST:<br />

LIMITS:<br />

Responsible Issuer<br />

• greater of 5% of market cap and $1,000,000<br />

Director of<br />

Responsible Issuer*<br />

• greater of $25,000 and 50% of aggregate of director’s compensation from the issuer<br />

and its affiliates in past 12 months<br />

Officer of<br />

Responsible Issuer*<br />

• greater of $25,000 and 50% of aggregate of officer’s compensation from the issuer<br />

and its affiliates in past 12 months<br />

Influential Person*<br />

• greater of 5% of market cap and $1,000,000, if not an individual<br />

• greater of $25,000 and 50% of aggregate of his or her compensation from the issuer<br />

and its affiliates, if an individual, in past 12 months<br />

Director or Officer of<br />

Influential Person*<br />

• greater of $25,000 and 50% of the aggregate of the director’s or officer’s compensation<br />

from the Influential Person and its affiliates in past 12 months<br />

Expert*<br />

• greater of $1,000,000 and the revenue that the expert and the affiliates of the expert<br />

have earned from the issuer and its affiliates in past 12 months<br />

Spokesperson*<br />

• greater of $25,000 and 50% of the aggregate of the person‘s compensation from the<br />

issuer and its affiliates in past 12 months<br />

* Limits do not apply if the plaintiff proves the defendant authorized, permitted or acquiesced in the making of the misrepresentation or the failure<br />

to make timely disclosure while knowing that it was a misrepresentation or failure to make timely disclosure, or influenced the making of the<br />

misrepresentation or the failure while knowing that it was a misrepresentation or failure to make timely disclosure. See also the discussion of<br />

proportionate liability in section 2.4.2. above.<br />

74 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


Proposed Corporate Governance Rules<br />

APPENDIX<br />

F


F<br />

Highlights of new proposed rules concerning<br />

corporate governance<br />

On June 27, 2003, the OSC (together with the securities regulatory authorities of all other Canadian jurisdictions, except<br />

British Columbia) published three new proposed rules for comment. These proposed rules respond to recent financial<br />

reporting scandals in the U.S., including Enron and Worldcom, and in light of U.S. Sarbanes-Oxley developments. The<br />

proposed rules:<br />

• require CEO and CFO certification of disclosure in companies’ annual and interim filings (Multilateral Instrument 52-109);<br />

• regulate the role and composition of audit committees (Multilateral Instrument 52-110); and<br />

• support the work of the new Canadian Public Accountability Board in its oversight of auditors of public companies<br />

(Multilateral Instrument 52-108).<br />

The comment period for the proposed rules extends until September 25, 2003 and the rules are expected to take effect on<br />

January 1, 2004.<br />

The substance of the proposed rules can be summarized as follows:<br />

CEO/CFO Certification<br />

Reflecting recent U.S. developments, the first of the new rules will require CEOs and CFOs of all Canadian public companies<br />

personally to certify:<br />

• that, to their knowledge, the issuer’s annual or interim filings, as the case may be, do not contain any<br />

misrepresentations or omissions and that they fairly present in all material respects the issuer’s financial condition,<br />

results of operations and cash flows. Annual and interim filings include an issuer’s annual information form, annual<br />

and interim financial statements and annual and interim MD&A. “Fair presentation” is indicated in a companion policy<br />

to refer to, without limitation, (i) the selection and proper application of appropriate accounting policies, (ii) the<br />

disclosure of financial information that is informative and reasonably reflects the underlying transactions, and (iii) the<br />

inclusion of additional disclosure necessary to provide investors with a materially accurate and complete picture of the<br />

issuer’s financial condition, results of operations and cash flows;<br />

• that they have designed (or caused to be designed under their supervision) and implemented disclosure controls and<br />

procedures and internal controls to provide reasonable assurances that (i) material information relating to the issuer is<br />

made known to them, particularly during the applicable time, and that such information is disclosed within the time<br />

periods specified under applicable securities legislation, and (ii) the issuer’s financial statements are fairly presented in<br />

accordance with generally accepted accounting principles;<br />

• that they have evaluated the effectiveness of the issuer’s disclosure controls and procedures and internal controls, and that<br />

their conclusions about the effectiveness of such disclosure controls and procedures and internal controls are disclosed in<br />

the annual MD&A;<br />

• that all significant deficiencies and material weaknesses in the issuer’s internal controls and any fraud, whether or not<br />

material, involving management or employees having a significant role in the issuer’s internal controls have been disclosed<br />

to the issuer’s audit committee and auditors; and<br />

• that the annual MD&A or interim MD&A, as the case may be, discloses whether any significant changes in the internal<br />

controls or in other factors that could significantly affect them were made during the period covered by the filings,<br />

including any correction of significant deficiencies or material weaknesses in such controls.<br />

Under a transitional feature of the proposed rule, the second through fifth bulleted paragraphs (regarding disclosure and internal<br />

controls) would only be required to be certified commencing January 1, 2005, in order to give issuers time to develop such<br />

controls to the certification level.<br />

The proposed rules do not define “disclosure controls and procedures” and “internal controls”, nor do they include an equivalent<br />

of the recently released SEC rules regarding management reporting on internal controls and the external auditor’s attestation to<br />

that report. However, OSC Chair David Brown has recently stated that the OSC will assess such rules and consider implementing<br />

comparable requirements in Ontario, including a requirement for auditor attestation.<br />

76 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


F<br />

Issuers that comply with U.S. federal securities laws and promptly file their U.S. certificates in Canada would be exempt from<br />

the certification requirements unless their financial statements are prepared in accordance with Canadian generally accepted<br />

accounting principles and are not filed together with U.S. certificates under U.S. federal securities laws. Certain foreign issuers,<br />

certain issuers of exchangeable securities and certain issuers of guaranteed securities would also be exempt from the certification<br />

requirements. Exemptive relief could also be granted by securities regulators.<br />

The wording of the certification must be exactly as set out in the proposed rules. An officer providing a false certification<br />

potentially could be subject to quasi-criminal, administrative or civil proceedings under securities laws.<br />

Role and Composition of Audit Committees<br />

As recently stated by OSC Chair David Brown, “to address the inherent conflict of interest and dangers of permitting<br />

management to oversee the relationship between an issuer and its external auditors”, the participating jurisdictions are<br />

proposing that:<br />

• audit committees have a minimum of three directors;<br />

• each member be independent;<br />

• each member be financially literate; and<br />

• each issuer disclose whether or not there is an audit committee financial expert serving on its audit committee and, if<br />

not, why not.<br />

The definition of independent is the absence of any direct or indirect material relationship with the issuer. This includes a<br />

relationship that could, in the view of the board of directors, reasonably interfere with the exercise of a director’s independent<br />

judgment. Certain prescribed relationships will cause a person to be considered to have a material relationship with the issuer,<br />

including, among others, (i) being an employee or officer of the issuer or an affiliated or subsidiary entity, (ii) being employed<br />

by the external auditor, and (iii) being a partner or executive officer of an entity providing paid accounting, consulting, legal,<br />

investment banking, or financial advisory services to the issuer. Family relationships may also lead to disqualification.<br />

Financial literacy is defined as the ability to read and understand a set of financial statements that present a breadth and level<br />

of complexity of accounting issues comparable to the breadth and complexity of the issues that can reasonably be expected to<br />

be raised by the issuer’s financial statements. An individual’s financial literacy must therefore be determined in relation to the<br />

issuer in question.<br />

The definition of audit committee financial expert is virtually identical to that adopted in the U.S., namely a person who<br />

has (i) an understanding of financial statements and the accounting principles used by the issuer to prepare its financial<br />

statements, (ii) the ability to assess the general application of such accounting principles in connection with the accounting<br />

for estimates, accruals and reserves, (iii) experience in preparing, auditing, analyzing or evaluating financial statements that<br />

present a breadth and level of complexity of accounting issues that are generally comparable to the breath and complexity of<br />

issues that can reasonably be expected to be raised by the issuer’s financial statements, or experience actively supervising one<br />

or more persons engaged in such activities, (iv) an understanding of internal controls and procedures for financial reporting,<br />

and (v) an understanding of audit committee functions.<br />

The audit committee’s responsibilities would explicitly relate to the appointment, compensation, retention and oversight of<br />

the external auditor, as well as to the pre-approval of all non-audit services to be provided by the external auditor. Audit<br />

committees must also have a written charter, and establish procedures to deal with allegations of accounting impropriety.<br />

Small issuers (i.e., those whose securities do not trade on the TSX, NYSE, ASE, NASDAQ National Market, NASDAQ<br />

SmallCap Market, Pacific Exchange or a non-Canadian and non-U.S. marketplace) will be exempt from the composition<br />

requirements and from the disclosure requirements. However, they will be required to comply with the remainder of the rule.<br />

In recognition of the unique needs of controlled companies, the draft rule permits an independent director of a public<br />

company to be a member of the audit committee of an affiliated entity. Thus, independent directors of a parent company<br />

would be permitted to be members of the audit committee of a subsidiary and vice versa.<br />

The rule would not apply to investment funds, issuers of asset-backed securities, certain subsidiaries and certain foreign issuers.<br />

STIKEMAN ELLIOTT LLP<br />

<strong>LITIGATION</strong> <strong>UNLEASHED</strong><br />

77


F<br />

Support of the Canadian Public Accountability Board<br />

Under Multilateral Instrument 52-108, financial statements of public companies can be audited only by a firm that is in good<br />

standing with the Canadian Public Accountability Board (“CPAB”). Good standing is maintained by entering into and<br />

abiding by a “participation agreement” with the CPAB, under which the audit firm agrees to submit to CPAB oversight,<br />

including ongoing inspections. The initial application must also be approved. Because the Alberta and Manitoba commissions<br />

do not have the authority to make rules governing auditors, firms in those provinces are technically not required to enter into<br />

participation agreements, as the Instrument recognizes.<br />

In all participating provinces except Alberta and Manitoba, audit firms will be required to notify the audit committee of any<br />

reporting issuer by which it has been engaged to issue an auditor’s report, as well as (in many cases) the local securities regulator,<br />

in the event that it is sanctioned by the CPAB. This notification must occur within 5 business days of the imposition of the<br />

sanctions. However, in the case of less serious “quality control” deficiencies, the audit firm will have the opportunity to correct<br />

the problem within an agreed period without issuing a notification to clients. Comments are being sought as to whether 5<br />

business days is a sufficient time.<br />

Most foreign issuers reporting in jurisdictions in which Multilateral Instrument 52-108 is adopted will be deemed in<br />

compliance with the requirement to use only auditors in “good standing” if they comply with the regulations of their home<br />

jurisdictions. However, their auditors will be required to enter into participation agreements with the CPAB. The Notice and<br />

Request for Comments accompanying the Instrument specifically requests comments on this point, and suggests that the<br />

CPAB may enter into reciprocal arrangements with oversight bodies in other jurisdictions with respect to foreign audit firms.<br />

These three proposed rules are Canadian measures designed to restore investor confidence. The participating jurisdictions<br />

believe that they will be as robust as those implemented in the U.S., but have designed them to reflect the differences in<br />

Canadian markets, especially the significant number of controlled companies and the generally smaller size and resources of<br />

Canadian public companies.<br />

78 <strong>LITIGATION</strong> <strong>UNLEASHED</strong> STIKEMAN ELLIOTT LLP


For more information, please call<br />

your usual <strong>Stikeman</strong> <strong>Elliott</strong> LLP contact<br />

or any of the following:<br />

William J. Braithwaite<br />

(416) 869-5654<br />

wbraithwaite@stikeman.com<br />

Mark E. Burton<br />

(613) 564-3467<br />

mburton@stikeman.com<br />

Bradley M. Davis<br />

(416) 869-5594<br />

bdavis@stikeman.com<br />

Peter F. C. Howard<br />

(416) 869-5613<br />

phoward@stikeman.com<br />

Katherine L. Kay<br />

(416) 869-5507<br />

kkay@stikeman.com<br />

Nathalie L. Mercure<br />

(416) 869-5658<br />

nmercure@stikeman.com<br />

Patrick J. O’Kelly<br />

(416) 869-5633<br />

pokelly@stikeman.com<br />

Simon Romano<br />

(416) 869-5596<br />

sromano@stikeman.com<br />

Edward J.Waitzer<br />

(416) 869-5587<br />

ewaitzer@stikeman.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!